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1. INTRODUCTION 
Understanding of skin absorption processes is needed not only for assessment of the 
safety aspects of chemicals, other xenobiotics, or cosmetic formulations but also to 
determine drug release of substances to the different skin strata and further to 
systemic circulation.  
 
 In the field of pharmaceutical sciences, drug delivery to the skin is gaining more and 
more interest, owing to the high acceptance by patients. In this regard, two different 
cases have to be distinguished: local delivery to selected skin layers (e.g., antimycotics) 
and systemic delivery (e.g., hormones). In the context of bioavailability assessment, 
knowledge on the absorption behavior of the active compound is essential. For ethical 
reasons, fundamental skin absorption data can normally not be obtained by 
conducting in vivo studies. Therefore, other techniques must be used to obtain the 
desired information. One option to obtain these data is the use of in vitro penetration 
and permeation models[1–3].   
1.1. Structure and Function of the Skin 
The skin is a complex organ and a living membrane. This constitutes one of the largest 
interfaces between the body and the environment[4]. The function of the skin include 
from the one hand protection against chemical, physical and microbial injury. On the 
other hand it is involved in the regulation of body temperature and water loss, defense 
and repair. The functionality of the skin depends on its highly differentiated structure, 
with the main barrier function being located in the outermost skin layer, the Stratum 
Corneum[5].  
1.1.1. Anatomical Structure of Human Skin 
The multitude of different functions of the human skin can only be achieved by a 
unique anatomical structure of the different skin layers (Figure 1). These are as 
follows: 
― epidermis consisting of 
 Stratum Corneum (outermost layer) 
 Viable epidermis 
― dermis 





Figure 1 Schematic picture of the native sub-classified into three main compartments: 
epidermis, dermis and subcutis (hypodermis). Skin appendices like hair with sebaceous 
glands, sweat glands as well as blood vessels are embedded in the skin. Image taken from 
Mathes et al.[6] 
1.1.1.1. Epidermis 
Human epidermis comprises about 5% of full-thickness skin and is generally divided 
into two main layers: the Stratum Corneum and the viable epidermis. 
The Stratum Corneum (SC) is the outermost cornified layer consisting of cells 
(corneocytes) that have lost their nucleus and all capacity for metabolic activity. 
Corneocytes are embedded in a lipid matrix or intercellular lipid lamellae. This 
structure is also known as the the brick (corneocytes) and mortar (lipids) structure 
(Figure 2). The SC is usually 10-25µm thick (excepting the soles of the feet and palms) 
and is crucial for the barrier function of the skin. Owing the relative impermeability of 
the cornified envelope to most compounds, the major route of penetration across the 
SC has been identified as the tortuous pathway between the corneocytes, implying 
that the lipid lamellae plays a key role in the skin barrier function. The hydrophobic 
lipids present in the intercellular spaces of the SC are 45-50% ceramides, 25% long 
chain free fatty acids (mostly chain lengths C22 and C24), and 5% of other lipids 
(cholesterol sulfate, cholesterol esters, ...) [7,8]. Some ceramide families are believed 
to play a different roles in skin properties[9]. Moreover, the free fatty acids cause the 
skin barrier to have a pH of 5.5, which affects the ionization state of the topically 
applied substances. 
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The intercellular lipids are arranged in layers (lamellae)(Figure 2) with two coexisting 
lamellar phases. These lamellar phases have a repeat distance of 6 nm (referred to as 
the SPP) or 13 nm (referred to as the LPP) [10–12]. There are three possible 
arrangements of the lipids: a very dense, ordered orthorhombic organization; a less 
dense, ordered hexagonal organization; and a disordered liquid organization. In 
healthy skin, lipids are mainly packed in an orthorhombic packing, while a small 
fraction of lipids adopts hexagonal packing [13–15]. In some inflammatory diseases, a 
higher fraction of the intercellular lipids assembles in a hexagonal packing, such as in 
atopic dermatitis[16]. This less dense lipid organization is associated with a reduced 
skin barrier function [17,18]. Also surfactants and organic solvents applied on the skin 
surface disrupt the barrier function of the skin an alter the lipid composition and 
organization [19].  
  
Figure 2 Lamellar and lateral organization in human Stratum Corneum. (1) Stratum 
Corneum containing corneocytes embeded in a lipid matrix. (2) Intercellular lipids 
arranged in layers (lamellae). (3) Coexisting lamellae phases. Image obtained from 
Janssens et al.[16] 
The viable epidermis is made of several non-vascularized layers: the stratum 
germinativum (or basal layer), followed by the stratum spinosum, the stratum 
granulosum and the stratum lucidum which is only present at the sole of the food and 
the palm of the hand (Figure 1). Over a 28 days cycle, cells originated in the stratum 
INTRODUCTION 
24 
germinativum migrate to the skin surface undergoing different differentiation states. 
The cells in doing so discharge lipids into the intercellullar space (stratum granulosum) 
lose their nuclei and get flattened and cornified building up the SC brick and mortar 
structure. Furthermore, the viable epidermis contains melanocytes, which produce 
melanin for light protection and Langerhans cells responsible for the immune 
response. 
1.1.1.2. Dermis 
The dermis provides the nutritional support for the avascular epidermis (Figure 1). The 
dermis consists of a matrix of connective tissue composed of collagen, elastin and 
reticulin interspersed by skin appendages pilosebaceous units and hair follicles. The 
dermis is the locus of sensory nerves, blood vessels and lymphatics. It contains the 
inner segments of the sweat glands and pilosebaceous units. Both can be responsible 
for systemic drug absorption by acting as sinks and keeping the concentration in the 
dermis low. 
1.1.1.3. Subcutis or subcutaneous fatty tissue 
This layers acts mainly as a heat insulator, a mechanical cushion and stores high energy 
chemicals. It consists primarily of loose connective tissue and lobules of fat. It contains 
larger blood vessels and nerves than those found in the dermis. 
1.1.2. Skin Absorption pathways 
Skin absorption pathways (Figure 3) can be divided into the transport (a) across the 
intact Stratum Corneum and (b) along using skin appendages. The physicochemical 
properties of the compound, as well as the used formulation, are the main factors 
influencing the choice of pathway. 
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Figure 3 Skin absorption pathways from Filon et al.[20] 
The Transappendageal Route 
The transappendageal route consists of the glandular and the follicular pathways 
(Figure 3), with the latter one being the more important. The chemicals bypass the 
corneocytes, entering the shunts provided by the hair follicles, sweat glands, and 
sebaceous glands.  
The follicular pathway is recently gaining importance.  Anatomically, the hair follicle 
embodies an invagination of the epidermis resulting in an increased surface area 
available for absorption of drugs[21]. Moreover, these invaginations are surrounded by 
numerous blood capillaries that facilitate the systemic absorption[22]. The presence of 
antigen presenting cells in the hair follicles is of special interest with regard to 
immunological therapy. Furthermore, recent studies showed that the hair follicle can 
be a long-term drug reservoir for up to 10 days[23,24]. 
 However, since appendages cover only 0.1% of the whole skin surface area, these 
pathways do not contribute significantly to dermal absorption during steady-state 
conditions of skin absorption. In contrast, in the initial stages of a skin absorption 
process and in the case of large hydrophilic compounds and ions, invasion through the 
appendages may play a considerable role. Recent studies also report that the 
appendages route may be involved in the absorption of liposomes, nanoparticles, and 
cyclodextrin-inclusion complexes[24,25]. 
Transport across the intact Stratum Corneum.  
Generally, the SC is considered to be the rate limiting layer of the skin with regard to 
transdermal drug absorption. Drug permeation across the SC depends on the 
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interaction between the skin, the drug and the other components within the 
formulation. 
Originating from the structure of the SC, two permeation pathways are possible: (a) 
the intercellular route and (b) the intracellular route (Figure 3).  
In the intracellular route, the chemical is transferred through the keratine-packed 
corneocytes by partitioning into and out of the cell membrane. It is not considered as 
the preferred way of dermal invasion, the reason being the very low permeability 
through the corneocytes and the obligation to partition several times from the more 
hydrophilic corneocytes into the lipid intercellular layers in the SC and vice versa. The 
intracellular pathway can gain in importance when a penetration enhancer is used, 
which may modify the corneocytes protein structure and hence changing their 
permeability. 
The intercellular route is the major route of penetration to most compounds, 
especially when steady-state conditions in the SC are reached. In this case the chemical 
is transferred around the corneocytes in the lipid-rich extracellular regions within the 
SC.  
Permeation of a chemical through the SC is basically a diffusion process in which active 
transport plays no role. For many compounds, the lipophilic SC is the rate-limiting 
barrier. However, diffusion through epidermis and dermis can be rate limiting for very 
lipophilic materials and/or when the SC is damages or affected by disease. 
Although this pathway is very tortuous and therefore much longer in distance than the 
overall thickness of the SC, the intercellular route is considered to yield much faster 
absorption due to the high diffusion coefficient of most drugs within the lipid bilayer. 
Resulting from the bilayer structure, the intercellular pathway provides hydrophilic and 
lipophilic regions, allowing more hydrophilic substances to use the hydrophilic and 
more lipophilic substances to use the lipophilic route. In addition, it is possible to 
influence this pathway by certain excipients in the formulation[26].  
1.2. Skin absorption methodologies 
Predicting human skin permeability of chemical actives efficiently and accurately is 
useful for developing dermatological medicines and cosmetics. The evaluation of 
percutaneous permeation of molecules is one of the main steps in the initial design 
and later evaluation of dermal or transdermal drug delivery. In vivo skin absorption 
studies are intrinsically rare, due to ethical, economical, and analytical concerns. 
Therefore, great efforts have been given to developing and validating alternative in 
vitro test methods[2,27,28]. A comprehensive compilation of literature data, 
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comparing the permeability of chemicals across animal and human skin in vivo, as well 
as in vitro, has been published by the European Centre for Ecotoxicology and 
Toxicology of Chemicals (ECETOC)[29]
.
 The diversity of existing in vitro and in vivo 
techniques shows the difficulties of comparing results between different methods, 
species, ages, as well as healthy and diseased skin. Howes et al.[30]
 
introduced a 
hierarchy of frequently applied in vitro methods for measuring percutaneous 
absorption which considers the resemblance to the in vivo situation (Figure 4). This 
knowledge can be very helpful when comparing different results of skin absorption 
studies. 
 
Figure 4 Hierarchy of commonly applied methods for studying percutaneous absorption 
considering their resemblance to the in vivo situation (adapted from Howes et al[30]) 
From the different scientific alternatives to investigate the percutaneous absorption 
phenomena it is now widely accepted that the transport processes of drugs in skin can 
be described by Fick’s first law[31]. This equation assumes that diffusion occurs in 
favor of the concentration gradient, in other words, from higher to lower 
concentration. This principle is applied in recent mathematical models used to 
describe the dermal absorption through the SC[32].The permeability constant (𝐾𝑝) is 
defined as the steady-state flux of chemical across the skin ( 𝐽𝑠𝑠) normalized by the 
concentration gradient (∆𝐶𝑣) and allows to compare results for different substances 
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For such reason the assessment of the permeability constant (𝐾𝑝) has been the main 
focus of permeation models.  
An introduction of the scientific knowledge of the different methods experimentally 
assayed in this doctoral thesis are presented as follows. 
1.2.1. In silico approaches/Mathematical models (QSPR) 
Quantitative structure permeability relationship (QSPR) models try to find a 
relationship between the logarithm of the permeability coefficient (log 𝐾𝑝) and 
molecular features (descriptors). Many data sets for skin permeability models employ 
the collection of the logarithms of permeability coefficients by Flynn[33] or subsets 
thereof. Despite that its reliability has been repeatedly questioned, the Flynn data set 
is still the most important source for developing QSPR models. 
A number of empirical models were proposed to relate the experimental permeability 
data, the octanol-water partition coefficient and the molecular weight of 
molecules[34–36]. Potts and Guy[37] took advantage of the Flynn’s large compilation 
to generate a widely cited equation (P-G)(Table II), in which Kow accounts for solute 
octanol-water partition coefficient, MW for molecular weight and 𝐾𝑝  for skin 
permeability coefficient. 
Other models predict the skin permeability by directly taking into account the diffusion 
pathway. Significant progress was made only very recently when Mitragotri (Mi)[38] 
presented a scaled particle theory on solute partition and diffusion across lipid 
bilayers. Relating the solute molecular radius to the molecular weight, Lian et al.[39] 
established that the equation formulated by Mitragotri can also be read as the Mi 
equation from Table II  in section 4.1.  
The Potts and Guy and the Mitragotri models have been widely reported in the 
literature; nonetheless, the Barratt model [40] was also selected because diverse 
physico-chemical properties were considered. Other attempts have been made to re-
model the permeability data by dividing them into smaller subsets. Following the 
removal of distinct classes, steroids were identified as outliers to QSPR models for 
permeability[40]. Further parameters were included to describe effects such as 
hydrogen bonding[41] and melting point[40]. The selected Barratt equation (Bar) is 
presented in Table II, and this equation represented the behavior of the largest 
     INTRODUCTION 
29 
number of molecules in their current dataset (which included 60 non-hydrocortisone 
molecules)[40].  
Finally, it has to be considered that transdermal penetration prediction through 
mathematical models based on structure-permeability of many compounds generally 
indicate their reliability for small subsets[39]. Therefore, these models predict the 
permeability of low molecular weight compounds and a mean lipophilicity. This is not 
the case for high hydrophilic compounds (particularly charged molecules) or for high 
lipophilic compounds[42].  
1.2.2. In vitro approaches 
Percutaneous penetration in man warrants in vivo experiments in humans. These 
experiments are often morally undesirable, expensive and time consuming. 
Additionally, high inter- and intra-individual variability is found in the data. Therefore, 
alternatives to in vivo studies in humans are sought. The suitability of the different in 
vitro permeability models using excised skin (human or animal) to mimic the in vivo 
studies has been widely reviewed[43,44], but obtaining a sufficient supply of excised 
human and animal skin is often a challenge and tends to be costly. 
There have also been attempts to create synthetic membranes that may be used as 
human skin models to investigate the transdermal diffusion properties of 
pharmaceutical and cosmetic compounds and formulations. The FDA has encouraged 
the use of porous synthetic membranes to evaluate the performance of topical 
products because they act as a support without posing a rate-limiting barrier[45]. 
Unlike skin, these membranes are inert and do not introduce biological variations. 
Moreover, the variability subjected to the anatomical site, age, race of the skin donor 
and skin-biopsy preparation and storage can be overtaken.  
In vitro skin permeation studies have been used for many years for the assessment of 
skin penetration drugs from topical or from transdermal products. Following the in 
vitro methodologies used in this thesis are described. 
1.2.2.1. Franz diffusion cells with skin biopsies or synthetic membranes  
The Franz diffusion cell is one of the most widely used systems for in vitro skin 
permeation studies[46]. With this methodology, any type or determinate amount of 
formulation (within the capacity of the donor chamber) may be applied to the skin or 
to synthetic membranes. Then the amount of drug that diffuses across the skin or 
membrane can be determined. Franz-type diffusion cell systems are relatively simple 
in design (Figure 5), with static diffusion cells that consist of the following two main 
parts: a receptor and a donor chamber. The membrane/skin is inserted between these 
INTRODUCTION 
30 
two compartments. The dose of the tested agent is applied into the donor chamber on 
the epidermal skin surface. An agent that permeates through the skin is accumulated 
in the receptor chamber (under the dermal skin surface), which is filled with the 
appropriate solution (receptor fluid in our case). After the exposure time, the skin 
sample can be processed to obtain the different skin layers. In that way, the 
distribution of the study compound can be determined.  
Because of its simplicity and cost-effectiveness, in this thesis Franz diffusion cells will 
be employed to study the drugs diffusion in a variety of membranes but also in pig skin 
in which the drug disposition in different skin layers could be studied. 
 
Figure 5 Details of Franz diffusion cell. Extracted from Ses-GMBH.  
Ex vivo porcine skin 
A wide range of animal models has been used as alternatives to human skin to 
evaluate percutaneous permeation of substances. These include pig, mouse, rat, 
guinea pig, and snake models.  
Porcine skin is histologically similar to human skin[47,48] with a comparable SC 
thickness of 21–26 μm[23,49] and when studying their Raman and infrared spectra 
they are found to be highly similar[50–52]. In addition, the average hair-follicle density 
in porcine ear skin is 20/cm
2
 compared to 14–32/cm
2
 in human forehead skin[23]. As 
well as being similar to human skin, porcine ear skin is also convenient to obtain and 
has been widely used in skin-permeation studies[53]. In a range of studies using both 
lipophilic[54,55] and hydrophilic[56] permeants, the permeability of pig skin was found 
to be similar to that of human skin, but to differ to a greater extent from dog or rodent 
skin. Sato et al.[56] attributed the similarity in permeability to the similar SC lipids, 
barrier thickness, and morphological aspects of pig and human skin. 
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The dermatomization technique may be used for harvesting skin, as well as for 
reduction of the dermal thickness. The recommended thickness is 400-700µm for pig 
skin[43] and normally is from the dorsal area. Samples comprise epidermis including 
SC, as well as part of the dermis (Figure 6). Although the dermatome will cut through 
hair follicle, the holes will readily close during incubation in aqueous media, due to 
swelling of the tissue. For such reason when the absorption through the hair follicle 
wants to be studied, non dermatomed skin (normally ear skin) should be employed. 
 
Figure 6 Scheme of different skin thickness used for dermal aborption studies  
 
Polymeric synthetic membranes 
Polymeric synthetic membranes are composed of a thin sheet of polymeric 
macromolecules that can control the passage of components through them. They may 
be composed of synthetic polymers (e.g., polysulfone and polycarbonate) or semi-
synthetic cellulose polymers (e.g., cellulose acetate and cellulose nitrate). These 
membranes can contain different structures and polymers that attempts to mimic the 
skin structure (Figure 7). Such membranes are then used in diffusion cells as skin 
surrogates. Despite their high reproducibility and simplicity, one of their restraints is 
the weaker barrier function compared to the skin, especially because of the difficulty 
to mimic the SC lipidic structure[19].  
The first efforts to study synthetic membranes and compare to skin absorption were 
carried out by Landmann in 1984[57]. More recently, Anwar and colleagues[58] 
developed a simplified model that should serve to a bridge gap between the more 
realistic but complex model systems and the simple models. The challenge here is to 
develop models that lend themselves to both molecular-level experiments and 
simulations. 
Dermatomed skin 
Full thickness skin 
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In this thesis, a new approach based on the polymeric synthetic membranes is 
proposed to create better skin surrogates. In a similar strategy than in skin-PAMPA in 
which ceramides and cholesterol are employed (section 1.2.2.2) lipidic components 
can be added to polymeric synthetic membranes to emulate the lipidic matrix. Due to 
the similarity with the SC composition, lanolin was selected and the obtained lanolin-
models were then evaluated. 
 
Figure 7 Cross section of a synthetic membrane (Strat-M®) and diagram of human skin. 
The Strat-M emulates in its structure three different layers of human skin. Image is 
extracted from Haq et al.[59] 
 
1.2.2.2. Skin Parallel Artificial Membrane Permeability Assay  
The Skin Parallel Artificial Membrane Permeability Assay (Skin-PAMPA) is an in vitro 
assay for skin penetration measurements. The skin-PAMPA membrane (Figure 8) was 
created by using cholesterol, free fatty acid and a ceramide along-analog compound 
that mimics the features of ceramides in the lipid matrix. The ceramide-analogue 
compound has been extensively used and its properties have been found to be 
suitable for PAMPA membrane.    
Based on a 96-well microtiter plate format, this system allows to screen compounds 
and to effectively predict their permeability by calculating the effective permeability 
coefficients (Pe). Testing compounds are applied in the donor solution to diffuse to the 
acceptor solution through the PAMPA membrane for a period of time (t) (Figure 8). 
Calculus are performed when concentrations in the acceptor well (CA)  and the donor 
well (CD) are determined[60]. 
 
Tight “skin” layer 
(SC in the skin) 
Polyether sulfone 
substructure 





in the skin) 
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Figure 8 Skin-PAMPA methodology overview. Image taken from Discovery Analytical 
Consulting©. 
 
This assay can predict transdermal penetration, establishing good correlation with 
human skin penetration[61,62] and hence allows a high throughput screening of a 
large number of drugs and pre-formulations at low cost. 
1.2.3. In vivo tape stripping technique 
In this technique SC is sequentialy substracted with adhesive tape strips (Figure 9).  
The skin-stripping approach was based on the concept that time profiles of the drug 
concentration in the outermost part of the epidermis, the SC, could characterize drug 
absorption (uptake) into the SC and drug elimination out of the SC into the deeper 
layers of the epidermis and dermis below, where clearance by the capillary loops of 
the circulatory system would occur[63]. The relevance of sampling the SC as a general 
way to evaluate topical bioequivalence was that differences in the rate and extent of 
the active moiety at nearby sites of action deeper in the epidermis or dermis were 
assumed to arise from differences in drug concentration profiles in the SC[64]. There is 
substantial evidence that supports this assumption. For example several studies with 
different products containing betamethasone dipropionate, betamethasone valerate, 
or triamcinolone acetonide[65–68] found a good correlation between the drug 
concentrations in the SC and the pharmacodynamic vasoconstriction (skin blanching) 
response produced by these glucocorticoids within the dermis, where the dermal 
vasculature resides. 
Taken collectively, there are several strengths of skin stripping as a pharmacokinetics-
based approach to evaluate the bioequivalence of topical dermatological drug 
products. Sampling of the SC by skin stripping is based on fundamental principles that 
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are rational and analogous to principles that are accepted for traditional 
pharmacokinetics-based bioequivalence assessments for systemically delivered drugs.  
In conclusion, tape stripping of the SC, is another commonly used technique that is 
minimally invasive so it can yield the concentration profiles of topically applied 
compounds in vivo after the tape strips quantification analysis.  
 
Figure 9 Removal of a layer of Stratum Corneum with an adhesive tape strip. Extracted 
from Au et al.[68]  
1.2.4. Spectroscopic techniques 
Over the last years, there has been an exponential increase in the use of Raman (RS) 
and Fourier transform infrared (FTIR) spectroscopic techniques in skin science and 
dermatology. Both provide a wealth of information on the cellular and molecular level 
from solid and liquid specimens without using external agents such as dyes, stains or 
radioactive labels [24-28]. These techniques are gaining more importance as valuable 
tools for the drug delivery, diagnose or clinical applications[69–71]. Both techniques 
detect molecular vibrations that depend on the composition and structure of the 
samples 
FTIR is a form of vibrational spectroscopy (Figure 10) that relies on the absorbance, 
transmittance or reflectance of infrared light. FTIR measures how much light is 
absorbed by the bonds of a vibrating molecule; that is, the remaining energy from the 
original light source after being passed through the substance. In comparison, Raman 
spectroscopy is based on Raman scattering, which is described as inelastic scattering of 
incident light from a sample and frequency shift by energy of its characteristic 
molecular vibrations (50–3500 cm
−1
 range) (Figure 10). The variation of energy during 
scattering is attributed to the interactions between chemical bonds involved in the 
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samples and the photon. The specific peaks originate from particular chemical bonds, 
allowing the application of RS technique in the semi-quantitative analysis. 
 
Figure 10 Diagram showing transitions occurring between energy levels during infrared 
absorption and Raman scattering phenomena. Extracted from Sulé-suso et al.[72] 
RS and FTIR differ in some key fundamental ways. RS depends on a change in 
polarizability of a molecule, whereas IR spectroscopy depends on a change in the 
dipole moment. RS measures relative frequencies at which a sample scatters radiation, 
unlike FTIR spectroscopy which measures absolute frequencies at which a sample 
absorbs radiation. In spite of the weak intensity of Raman phenomena, it has two 
major advantages. Firstly, water, commonly present in biological samples, shows only 
slight Raman scattering and very strong FTIR absorption. Secondly, since in Raman and 
FTIR spectra the same vibrational states are assessed, Raman spectra are composed of 
narrower bands than FTIR spectra. Overall, despite their differences, both techniques 
serve the purpose of identifying unknown substances. Molecules that cannot be 
detected with the one method can be easily detected with the other, and that leads 
researchers to use them both in a complementary way. 
In this doctoral thesis different techniques based on FTIR and RS are employed: 
confocal Raman microscopy, attenuated total reflection Fourier transform infrared 
spectroscopy and Synchrotron-Based Fourier Transform Infrared microspectroscopy. 
In confocal Raman microscopy (CRM) a confocal microscope is added to a Raman 
spectrometer allowing the acquisition of spectra with high spatial resolution in the z 
dimension (depth line), in x-z dimension (depth slice) and also in x, y and z dimensions 
(tridimensional data). Then 2D or 3D images of the relative abundance of biomolecules 
can be determined based in the intensity of Raman bands or in powerful spectroscopic 
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analysis. The technique bears tremendous potential for diverse skin applications 
ranging from the analysis of physiological component distribution in skin tissue and the 
diagnosis of pathological states up to biopharmaceutical investigations such as drug 
penetration kinetics within the different tissue layers[73].   
Attenuated total reflection Fourier transform infrared (ATR-FTIR) offers another way in 
FTIR to record spectra from non-transparent biomedical samples. At the interface 
between an ATR crystal of high refractive index and the sample of lower refraction 
index, an evanescent wave penetrates a few micrometers into the sample. The 
spectrum collected represents then the average signal from the area of the sample 
that the light passed through.  
Synchrotron-Based Fourier Transform Infrared microspectroscopy (µFTIR) is a 
conventional infrared spectrometer with very little modifications to be adapted to the 
synchrotron infrared source and to a microscope. These modifications represent a 
significant enhancement over the conventional IR. Through a 10-μm pinhole, the 
brightness of a synchrotron source is 100–1000 times higher than a conventional 
thermal (globar) source. Accordingly, the improvement in spatial resolution and in 
spectral quality to the diffraction limit has led to a plethora of applications that is just 
being realized. Some authors studied simultaneously skin composition, structure and 
molecule penetration[74]. Others have been used µFTIR to study the effect of 
penetration enhancers on SC lipidic structure and to follow exogenous molecule 
penetration[75]. 
The spectral analysis is a crucial step to extract conclusions of the experiments in RS 
but also in FTIR. To extract information of the spectra many mathematical calculus can 
be performed: baseline, normalization, second derivative, principal component 
analysis, etc. 
Moreover when the spectral contribution of a substance wants to be determined other 
methods arise. In this thesis peak fitting, classical least squares (CLS) and multivariate 
curve resolution-alternative least squares (MCR-ALS) analysis will be performed. 
Peaks and spectral bands are usually studied with peak fitting method. Experimentally 
measured bands or peaks are fitted with theoretical models that create individual 
peaks from a spectrum that, when added together, match the original data. Then, the 
peak parameters like amplitude, intensity or the peak position can be easily 
determined and subsequently studied in detail.  
To apply the classical least squares regression (CLS)[76] to the spectral data, the pure 
compound spectrum of each constituent (loadings) is required. Then the contribution 
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(scores) of each loading in the dataset can be calculated. These scores are used to 
create a map showing the distribution of each reference spectrum.  
Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS)[77] has been 
widely used for different applications of Raman-based hyperspectral imaging[78] and 
determination of skin penetration of substances[79]. Similarly to CLS, MCR-ALS can 
recover the concentration and pure spectra of analytes of interest and can additionally 
estimate the spectra of possible interferences. This method has proved to be 
particularly useful in cases, where spectra of the pure substances were not 
available[80–83]. However, with this method, known reference spectra can be also 
used as a starting point for the calculation. Similar to CLS, the algorithm will calculate 
the scores and loadings of each component to create a 2D image. 
In the present thesis CRM, ATR-FTIR and µFTIR techniques will be used not only to 
study the molecular disposition and penetration within the skin, but also to study the 
absorption of substances and the molecular changes that the actives or the vehicles 




















2. AIMS  
The main aim of this work is to evaluate different in silico, in vitro and in vivo methods 
to asses skin permeability of active molecules, to select in the future the appropriate 
ones to be included in screening cascades of novel drugs. To this end a group of topical 
molecules for different indication and with diverse physico-chemical properties were 
selected. Correlation of methodologies was sought also to increase understanding of 
active penetration through the skin.  
This main aim can be split into the following specific objectives:  
― To seek for correlation on permeability behavior of in silico Quantitative 
structure permeability relationship (QSPR) models and in vitro skin-PAMPA and 
Franz diffusion cells with synthetic membranes and pig skin respectively. 
― To determine the effect of vehicles on skin permeation using Franz diffusion cells 
with pig skin to be related with their physicochemical properties and clinical 
efficacy. 
― To demonstrate the enhancer effect of propylene glycol based on skin 
modification. 
― To design and obtain new synthetic membranes containing lanolin with improved 
membrane barrier to better emulate mammal skin on in vitro permeation 
models.  
― To validate the Franz diffusion cells with pig skin with in vivo stripping results. 
― To improve the confocal Raman spectroscopy methodology to achieve 
quantitative analyses to be correlated with Franz diffusion cell results. 
― To demonstrate the suitability of confocal Raman microscopy to study structural 





















3. MATERIALS  
3.1. Porcine skin 
In accordance with an approved Institutional Animal Care and Use Committee 
protocol, unboiled porcine skin was obtained from the dorsal area (dermatomed skin) 
or the ear (non-dermatomed skin) of weanling female white/Landrace pigs weighing 
30-40 kg. The skin was provided by the Clinic Hospital of Barcelona. Following 
euthanasia of the pigs, the bristlers were removed carefully with an animal clipper and 
were subsequently gently washed with water.  
If dermatomed skin was needed, the hair-clipped skin was dermatomed with a 
Dermatome GA630 (Aesculap, Germany) to a thickness ranging from 500±50 µm, cut in 
appropriate pieces (2.5 cm inner diameter) and then sealed and stored under vacuum 
at -20ºC until their use. 
3.2. Synthetic membranes 
The Skin-PAMPA™ sandwiches were purchased from Pion INC (precoated permeability 
plates; P/N 120691) and were used after an overnight hydration with hydration 
solution (Pion P/N 120706). The full set up process is described in section 4.2. 
Two different polymeric membranes were employed as surrogates for creating a new 
synthetic membranes containing lanolin: StratM® (Merck Milipore, Germany) and 
Nuclepore® (Sigma-Aldrich, USA).  
3.3. Actives  
A vast number of topical actives were employed in this thesis to study and compare 
the different permeation models. Table I contains a list of the actives as well as some 
other characteristics to show the high diversity of the subset. 
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Table I Compound (abbreviation), CAS number, manufacturer, main indication and 
ionization state of the selected substances. 
Compound 
(Abbreviation) 
CAS Number Manufacturer Indicaction Ioniz. State 
Azelaic acid (Az) 123-99-9 Sigma Acne  Acid 
Betamethasone 
dipropionate (Bet) 
5593-20-4 Sigma Inflammation Neutral 
Bexarotene (Bex) 153559-49-0 Selleck Lymphoma Acid 






147657-22-5 MatTek Psoriasis Neutral 
Clindamycin (Cli) 18323-44-9 Axon Medchem Antibacterial acne  Basic 
Clobetasol propionate 
(Clo) 
25122-46-7 AK Scientific Inflammation Neutral 
Dapsone (Dap) 80-08-0 Fluka Antibacterial Neutral 
Diclofenac sodium 
(Dic) 
15307-79-6 Sigma Actinic keratosis Acid 
Diphenhydramine 
(Dip)  
58-73-1 Pacific Pruritus Basic 
Eflornithine (Efl)  70052-12-9 
Chem-Impex 
International 
Facial hirsutism Zwitterion 
Finasteride (Fin)  98319-26-7 Fluka Alopecia Neutral 
Fluorouracil (Fo) 51-21-8 Sigma Actinic keratosis Neutral 
Flurandrenolide (Fra) 1524-88-5 Sigma Eczema, psoriasis Acid 






Imiquimod (Imi) 99011-02-6 Ak Scientific Actinic keratosis Neutral 
Ketoconazole (Ket) 65277-42-1 Intex Quimica Fungal infection Neutral 
Lidocaine (Lid) 137-58-6 Sigma Pain Basic 
Nicotine (Nic) 22083-74-5 Tocris, UK Smoking addiction Basic 
Resveratrol (Res) 501-36-0 Sigma , USA Antioxidant Neutral 
Salicylic acid (Sal) 69-72-7 Sigma Acne , psoriasis Acid 
Tacrolimus 
monohydrate (Tac)   
109581-93-3 LC Laboratories Atopic dermatitis Neutral 




Terbinafine (Ter) 91161-71-6 Selleck Onychomicosis Basic 

















4. METHODS  
4.1. In silico skin permeability models: QSPR 
Three mathematical models were used to predict the skin permeability coefficient (𝐾𝑝 
in cm/s) or the facility of the compound to permeate across the skin (Table II). The 
Potts and Guy equation (P-G) and the Mitragotri equation (Mi) take into account the 
molecular weight (MW) and the solute octanol-water partition coefficient (Kow). The 
third mathematical model was the Barratt equation (Barr), which, in addition to the 
octanol-water partition coefficient, takes into account MV as the molecular volume 
and MP for the melting point.  
Table II Mathematical Models for Predicting Skin Permeability; Mitragotri (Mi), Potts and 
Guy (P-G) and Barratt (Bar) models 
Model Equation 
P-G Equation[37] 𝑙𝑜𝑔 𝐾𝑝 = 0.71 𝑙𝑜𝑔 𝐾𝑜𝑤 −  0.0061𝑀𝑊 − 6.3  
Mi Equation[38,39] 𝑙𝑜𝑔𝐾𝑝 = 0.7 𝑙𝑜𝑔 𝐾𝑜𝑤 − 0.0722 𝑀𝑊
2
3 − 5.2518 
Bar Equation[40] 𝑙𝑜𝑔 𝐾𝑝 = 0.82 𝑙𝑜𝑔 𝐾𝑜𝑤 − 0.0093 𝑀𝑉 − 0.039𝑀𝑃 − 2.36 
 
The three models consider the substance lipophilicity, an important parameter that 
affects skin permeation. To study the permeability in our subset of compounds, the 
calculus for log 𝐾𝑝 was performed with the distribution coefficient (log 𝐷) at pH 5.5 
(skin surface pH) where the molecules can be ionized. 
Two different software platforms, ChemAxon algorythm (Chemaxon, Hungary) and 
BIOVIA PipelinePilot (Accelrys, USA) were employed to obtain the distribution 
coefficient at pH=5.5 (log 𝐷 pH 5.5) and the molecular weight (MW). The molecular 
volume was obtained from the BIOVIA PipelinePilot application software. 
The melting points (MP) of pure compounds were measured in a Büchi B-540 in 
Almirall R&D Centre. The melting point was calculated with the medium value 
obtained between the temperature in which a visual modification of the solid form 
was observed and the final temperature in which the transition was completed. The 
increment of the temperature was approximately 1ºC/min. 
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4.2. Skin Parallel Artificial Membrane Permeability Assay (skin-
PAMPA) 
Skin-PAMPA is a high throughput screening in vitro assay used to study the 
transcellular permeation of compounds. Active permeabilities were studied when they 
were solved in a solution at the physiological skin surface pH (5.5) and in propylene 
glycol (PG) which is a commonly employed cosolvent-enhancer. Assays were 
performed in Almirall R&D Centre. Each active was diluted in propylene glycol (Sigma 
Aldrich, USA) or a buffer solution (Pion, No. P/N 110151 50 mL) at 20 µM. In both 
cases, a 2% v/v of dimethyl sulfoxide (DMSO) (Sigma-Aldrich, USA)  was employed.   
Before forming the sandwich (Figure 8), the bottom (donor) plate was filled with 200 
µL of the previously described solution. The acceptor plate was filled with 200 µL of 
fresh Prisma HT Buffer at pH 7.4 and containing 2% v/v DMSO. The resultant sandwich 
was incubated for 5 h at room temperature. After the permeation time, the PAMPA 
sandwich was separated, and 100 µL of both the donor and acceptor compartments 
was transferred to UPLC plates.  The analytical procedure followed for their analysis is 
detailed in section 4.6.2. 
4.3. Permeation studies with Franz diffusion cells 
The absorption penetration profile was studied with the Franz cell assay. Such assay 
was widely employed in this thesis and allows not only the study of absorption through 
membranes or through skin biopsies. Moreover when working with skin, the amounts 
of substance can be determined in different layers.  
Static Franz diffusion cells (Lara-Spiral, Courtenon, France) with a nominal surface area 
of 1.86 cm
2
, and the receiver compartment capacity with approximately 3 mL were 
employed. The OECD Guidelines[84] and the published opinions of the Scientific 
Committee on Cosmetic Products and Non-Food Products[85] were closely adhered to 
during this study. Additionally, several other classical and updated principles of 
percutaneous absorption were considered[86]. 
The employed membrane/skin was thawed and mounted with the top/SC side facing 
the donor compartment. The receptor chamber was filled with receptor fluid (RF), 
Dulbecco phosphate-buffered saline at pH 7.4 (Sigma, St. Louis MO, USA) in MiliQ 
water with the addition of 0.04% (w/v) and gentamicin sulfate salt (Sigma, USA). 
Nevertheless in the case of poorly hydrophilic substances its solubility within the 
receptor fluid can be an impediment for its diffusion. To overtake this impediment, a 
5% (w/v) of bovine serum albumin (Sigma, USA) was also added following the 
recommendations of OECD2010 to increase the uptake of lipophillic compounds[87]. 
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Air bubbles were carefully removed between the skin and the RF. The RF was agitated 
with a magnetic stirring bar. 
The assembled Franz-type cell was placed in a thermostatically controlled water bath 
maintained at 37ºC containing a magnetic stirring device, and the skin surface 
temperature was maintained at approximately 32ºC. To eliminate the damaged skin, 
the transepidermal water loss value (TEWL) was measured with a Tewameter TM210 
(Courage & Khazaka, Cologne, Germany) at the moment of the formula application, 
considering correct TEWL values under 15 g/m
2
/h. 
At this point, 20 µL of each formulation was applied to the top of the membrane/skin 
delimited by the upper cell. At 24 h, receptor fluid was collected and extracted) was 
transferred to a 5-mL volumetric flask and stored at -20ºC until analysis. 
 In the case of skin, the different skin layers were separated as follows. Skin surface 
was washed and wiped with a cotton bud to remove any remaining formulation. Then, 
8 strippings were carried out on the surface horny layers of the SC with strips of 
adhesive tape (D-Squame, Cuderm Corporation, Dallas, USA) applied under controlled 
pressure. Lastly, the epidermis was separated from the dermis after heating the skin at 
80ºC for several seconds.  
The extractor employed solvents were different depending on whether the analysis 
was carried out by UPLC-MS/MS (section 4.6.2) or HPLC-DAD (section 4.6.1). The wash 
and the cotton bud were extracted into 10 mL of solvent (W). The strips were 
extracted into 2 mL. The Stratum Corneum value (SC), epidermis (E) and dermis (D) 
were appropriately extracted into 1 mL extractor solvent. The different skin samples 
were extracted appropriately in 1 mL of extractor solvent. 
4.4. Design new lanolin synthetic membranes  
The addition of lanolin is proposed as a strategy to emulate the lipidic matrix and 
therefore increase the permeation similarity between normal skin and synthetic 
membranes to be applied to in vitro permeation methodologies previously described. 
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Figure 11 Lanolin addition to polymeric synthetic membranes and Franz-cell assembly 
Lanolin was extracted from Spanish merino sheep’s using the WDS process which is 
detailed in the LIFE 11 ENV/ES/588 project[88]. In brief, the wool was scured with 
hexane, to remove dust impurities the hexane solution was centrifuged and lanolin’s 
recovered from the hexane with distillation at 35ºC. Finally lanolin was desiccated to 
remove the residual water. 
Addition of lanolin was performed to the Strat-M  and Nuclepore membranes (Figure 
11). In Strat-M membranes, 100 µL of lanolin 5% in hexane:ethanol 96% (2:1) solution 
was applied three times on the top of the membranes under N2 flow. Next, these Strat-
M-lanolin membranes were stored at 85°C for 10 minutes to fix the lipids and dry the 
membrane. Lanolin was also added to the Nuclepore membranes following the more 
complex procedure for lipid fixation previously detailed by Pullmannová et al.[89], 
wherein the membranes were hydrated in hexane:ethanol 96% (2:1) and then dried at 
room temperature. Under N2, 100 µL of lanolin 5% in hexane:ethanol 96% (2:1) was 
applied on the top. The membranes were stored at 2-6°C in a vacuum desiccator for 24 
h. Finally, the membranes were placed at 85°C for 10 minutes and, after 3 h at room 
temperature, the membranes were ready to use.  
Each studied membrane was mounted in a Franz-type cell following the method of 
section 4.3. TEWL, as an indicator of the membrane integrity/barrier function, was 
acquired after system stabilization and nine replicates for every model were evaluated 
during 24h. Once the results were obtained, the Kruskal-Wallis test was performed to 
detect significant differences between the pig skin and the different models. So then, 
the barrier function improvement and similarity against porcine skin after the lanolin 






4.5. In vivo tape stripping methodology 
Six volunteers (all women) with no history of dermatological disease participated in 
this study, which was approved by the Ethics Committee (IQAC-CSIC, Barcelona, Spain). 
Specific information of the study was given to the participants, and their written 
consents were obtained. The median age of the volunteers was 33 years, ranging 
between 25 and 42 years, and phototypes II, III and IV were included[90]. The treated 
sites (2 × 1 cm) were the non-hairy areas of the ventral forearm surface. The 
administration involved application of 10 µL/cm
2
 of active solution, according to 
reported guidelines[84]. This amount represents 500 µg of the total amount of active 
per area (cm
2
). The application was non-occlusive. 
The active permeation profile across the SC was determined with the widely detailed 
[91,92] stripping method. After an application time of 24 h, a sequential removal of the 
outer skin layers from each volunteer was carried out by tape stripping (D-Squame™ 
tapes, ø = 22 mm, CuDerm, Dallas, USA). Each tape was fixed to the skin surface using a 
specific device that exerted a constant pressure of 80 g/cm
2
 for 5s, and the tape was 
removed from the test area with a gentle movement. For each repeated strip, the tear-
off direction was varied to obtain homogeneous removal of the SC cell layers. A total 
of ten tape strips were used on all the treated sites. 
4.6. Extraction and analysis 
The quantification of the actives in the different samples was done with two different 
devices: HPLC-DAD and UPLC-MS/MS. Actives were quantified and extracted 
accordingly with the different experiments. The extractor solvent for compounds 
analysed with HPLC-DAD are detailed on Table III (section 4.6.1) while ACN-TFA was 
the extractor solvent of all compounds analyzed with UPLC-MS/MS (section 4.6.2).  
In both cases after the analysis, the results were presented as normalized amounts (%) 
of permeated substance with their standard deviation. The permeated amounts (ABS)  
in the case of skin was considered the sum of the epidermis, dermis and receptor fluid. 
For the rest of the membranes, the amounts were found to be equivalent to those in 
the receptor fluid.  
4.6.1. High performance liquid chromatography (HPLC-DAD) 
Before the HPLC analysis, all the extracts were sonicated 15minutes and filtered with a 
0.45µm Nylon filter (Cameo, USA). The amount of active in the samples was 
determined by HPLC methodology validated according to ICH Q2 (R1) guidelines in 
terms of linearity, accuracy and precision[93]. The HPLC system consisted of a WVR-
Hitachi HPLC with a CM5430 DAD detector, L-2130 Pump, L-2200 Autosampler, and an 
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Interfase. The flow rate was 1 mL/min under isocratic conditions, and the injection 
volume was 20 μL. The columns, wavelengths and mobile phases as well as calibration 
curve for every active are compiled in Table III. 
Table III HPLC analytical conditions for lidocaine (Lid), diclofenac sodium (Dic), 
betamethasone dipropionate (Bet), caffeine (Caf) and Resveratrol (Res). Employed 
abbreviations: Excitation wavelength (λ) in nanometers; Retention time (Tr) in minutes; 
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𝐴 = 17608[𝐶𝑎𝑓] − 1048.8 
(0.9999) 







5% acetic  
48% water 
𝐴 = 52321[𝑅𝑒𝑠] − 21132 
(0.9998) 
 
4.6.2. Ultra performance liquid chromatography-tandem mass spectrometer 
(UPLC-MS/MS) 
Wash, D-Squame tapes, epidermis and dermis samples were extracted with 
acetonitrile (Sigma, USA) with 0.5% of trifluoroacetic acid (Sigma, USA) (ACN-TFA 0.5%) 
and diluted with water 1:3 (v/v) before the analysis by UPLC-MS/MS. Receptor fluid 
sample levels were determined by UPLC-MS/MS after protein precipitation with ACN-
TFA 0.5%, centrifugation at 4000 rpm for 10 min (4ºC) and dilution of the supernatant 
with water 1:3 (v/v).  
All the UPLC-MS/MS analysis were performed in Almirall R&D center. The MS detector 
used was Waters XEVO TQS. The column used was a Waters Acquity UPLCTM BEH C18 
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(1.7 µm, 2.1x50 mm), and it was maintained at 40ºC. The autosampler temperature 
was 8ºC. The mobile phase A contained 0.05% HCOOH+2.5 mM of NH3 (pH 3), and the 
mobile phase B was acetonitrile (ACN). The flow remained stable at 0.400 µL/min for 
all the compounds. The analytical conditions for the actives are detailed in Table IV. 
Table IV Analytical UPLC conditions. Employed abbreviations: Time 0 (i); Cone voltage 
(CV) in V; Collision energy in eV (EC); Excitation wavelength (λ) in nanometers; Retention 










% Phase A (time) λ (nm) Tr (min) 
Aze 187.10 125.0 25 20 85 (i)- 55 (1 min)- 5 (1.10 min)- 85 (1.70 min) NA* 1.15-1.2 
Bet 505.25 279.1 20 20 55 (i)-  5 (1 min)- 55 (1.70 min) 254 1.05 
Bex 347.21 186.0 50 - 20 (i)- 5 (1 min)- 20 (1.70 min) 258 0.99 
Cal 395.1 105 15 35 85 (i)- 5 (2 min)- 85 (2.20 min) 265 1.85 
Cli 425.18 126.0 45 25 85 (i)- 55 (1 min)- 5 (1.10 min)- 85 (1.70 min) 200-400 1.04 
Clo 467.19 278.0 50 25 20 (i)- 5 (1 min)- 1.70 (20 min) 246 1.07 
Dap 249.06 92.0 30 20 85 (i)- 60 (1 min)- 5 (1.10 min)- 85 (1.70 min) 295 1.10 
Dic 296.02 215.1 20 20 65 (i)- 5 (1 min)- 65 (1.70 min) 277 1.08 
Dip 255.16 167.1 30 20 85 (i)-35 (1min)- 5 (1.10 min)-85 (1.70 min) 220 1.08 
Efl 183 120 20 30 5 (i)- 95 (3 min)- 5 (3.10 min) NS** 1.82 
Fin 373.28 57 45 40 65 (i)- 20 (1 min)- 5 (1.10  min)- 65 (1.70 min) 204 1.0 
Fo 129 86 35 15 5 (i)- 95 (3 min)- 5 (3.20 min) 266 0.4 
Fra 437.3 361 5 15 62(i)- 45 (0.70 min)- 5 (1.10 min)- 62 (1.20 min) NS** 0.6 
Gly 319.21 116.1 40 25 20 (i)- 5 (1 min)- 20 (1.70min) 237 1.14 
Imi  241.14 185.1 50 20 85 (i)- 55 (1min)- 5 (1.10 min)- 85 (1.70 min) 245 1.14 
Ket 531.15 82 40 25 75 (i)- 40 (1 min)- 5 (1.10 min)-75 (1.70 min) 243 1.07 
Lid 235.17 86.1 40 20 95 (i)- 60 (1 min)- 5 (1.10 min)- 95 (1.70 min) 277 1.08 
Nic 163 132 30 20 85 (i)- 35 (4.10 min)- 5 (4.20 min) 260 1.10 
Sal 137 93 45 20 95 (i)- 44 (3 min)- 10 (3.10 min)- 95 (3.20 min) 301 1.86 
Tac 804.48 768.0 35 20 45 (i)- 5 (1 min)- 45 (1.70 min) 200-400 1.23 
Taz 352.3 324.1 50 25 71 (i)- 88 (0.70 min)- 95 (0.80)- 71 (1.20 min) NS** 0.60 
Ter 292.2 141 30 20 65 (i)- 5 (1 min)- 65 (1.70 min) 284 0.98 
Tof 313.3 149 45 25 95 (i)- 75 (1 min)- 5 (1.10 min)- 95 (1.70 min) 290 1.21 
*NA: not applicable **NS: no signal  
4.7. Confocal Raman microscopy 
Two different measurements were employed in this doctoral thesis with confocal 
Raman microscopy. From one side, in the depth profiling (Figure 12A), the Raman 
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spectra were obtained measuring the treated skin in the z-axis (depth). From the other 
side in the imaging the Raman spectra were acquired in the x-y axis in a skin cross-
section so an image of the spectral information can be obtained (Figure 12B). 
 
 
Figure 12 A. Depth profiling: Raman spectra are recorded along a z-directed line, peak 
intensities are depicted as intensity profiles against depth. B. Imaging: Raman spectra are 
acquired in the x–y direction; intensities are represented by color in a two dimentional 
picture Figure is adapted from Franzen et al. [94] 
 
4.7.1. Depth profiling of substances into the skin 
Confocal Raman microscopy (CRM) allows the study of the diffusion through the skin 
of substances by studying the skin spectral changes when going in depth (z-axis) into a 
sample, especially with substances with bands that are not overlapped with the skin 
spectra. This semi-quantitative technique has been optimized to achieve a quantitative 
assay, both methodologies are described below.  
Raman spectra acquisition 
Raman spectra were acquired using a Renishaw (Gloucestershire, UK) Model inVia 
confocal Raman microscope in Almirall R&D Centre. Excitation (approximately 100 mW 
at the sample) was provided by a 532 nm diode laser. The exciting laser radiation was 
coupled to the microscope through a wavelength-specific mode optical fiber. The 
incident laser beam was collimated via a lens and passed through a holographic band 
pass filter before it was focused onto the sample through the objective of the 
microscope. A Leica 50x/0.75 NA objective was used in this study. Spectra were 
METHODS 
57 
acquired using a 1 s exposure time, 3 accumulations and an 1800 line/mm grating. The 
spectral resolution was approximately 1 cm
-1
, and the spectral window ranged from 




For the quantitative detection with CRM, different biopsies of tissue were incubated at 
different active concentrations and then analyzed with Raman. Therefore, when a 
specific band of the substance is observed, its intensity can be related to the solution 
concentration. Finally when analyzing the sample at different depths, the obtained 
intensities can be correlated with the different concentrations. 
The active was solved in phosphate buffered saline solution at pH 7.6 (Sigma-Aldrich, 
St. Louis, MO, USA) to reach solutions containing a wide range of concentrations (see 
results of caffeine in section 5.4.1). 
For incubation experiments, epidermis (Ep) was separated from the dermis after heat 
dry treatment at 80ºC for few seconds. Each Ep sample was weighted previous 
immersion in a specific solution. The mean of weight of Ep samples was 10.84 ± 1.57 
mg. Ep samples were completely immersed in 3 mL of each solution by triplicate, 
during 20h. Afterwards, the Ep was removed and dried between two filter papers 
under controlled pressure (80g/cm² for 10 seconds). The content of active from Ep was 
analysed by confocal Raman microscopy (CRM) (detailed above) and quantified by 
HPLC-DAD (section 4.6.1). 
4.7.2. Imaging of transfollicular penetration of caffeine with Confocal Raman 
microscopy  
Confocal Raman microscopy (CRM) was here used to image the follicular penetration 
of caffeine vehiculized in nanoparticles (Caf-NP) and aqueous solution (Caf-Aq). 
Cryosections of porcine skin applied with each formulation are analyzed with CRM. The 
obtained spectra are analyzed with different spectroscopic methods to create 2D 
images of caffeine distribution. 
All the different processes described in this section were performed in the Center of 
Experimental and Applied Cutaneous Physiology (CCP) placed in Berlin. 
Skin sample preparation 
A test area of 2×3 cm were marked on non dermatomed porcine ear skin (section 3.1) 
using window color (Marabu GmbH & Co KG, Tamm, Germany) for every formulation 
and one for non-treated skin (NT). 10 µL/cm
2
 of caffeine formulation were applied on 
the surface of the test area. In order to simulate the in vivo situation, the selected 
areas were massaged 2 min using a massage applicator (Minivibrator RFM, Rehaforum 
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Medical GmbH, Elmshorn, Germany) after topical application of the formulation. The 
formulations were allowed to penetrate for 30 min.  
After 30 min of penetration time, biopsies of the treated and the non-treated areas 
were taken using a scalpel. Cryospray (Cryo-Spray, SLEE medical GmbH, Mainz, 
Germany) was applied to facilitate separation of the skin samples from the underlying 
tissue. The biopsies were flattened between two glass slides, again fixed with 
cryospray and finally placed in liquid nitrogen and subsequently stored in a freezer at -
20 °C until further use. The cross-sectional tissue samples of the biopsies were 
prepared using a cryomicrotome (Cryostat Microm HM 560, Microm International 
GmbH, Walldorf, Germany). 
Each biopsy was embedded in Tissue freezing medium (Leica Biosystems Nussloch 
GmbH,  Germany) on a metal sample holder inside the cryomicrotome at -30°C. The 
embedded skin was sectioned into 30 µm slices by microtome blades before being 
placed onto Superfrost glass slides (Carl Roth GmbH + Co KG, Karlsruhe, Germany) and 
for later analysis stored at -20 °C. For the subsequent measurements, the sections on 
hair follicles were selected. 
CRM mapping acquisition 
Measurements of cross-sections were performed using a Labram HR800 Evolution 
CRM (Horiba Jobin Yvon, France) in the fingerprint region (400–2500 cm
-1
) with 
excitation at 473 nm and 6.1 mW optical power on the sample surface and a spectral 
resolution of <4 cm
-1
. The following settings were employed: grating of 600 g/mm, 
100× objective, spot of 0.85 µm and 5 s of exposure time per spectrum. The 
microscopic images of the hair follicles were collected with a 10× objective. 
The Autofocus reflection mode integrated in the Labspec software (Horiba Jobin Yvon, 
France) was employed for the detections of the sample surface for every position. The 
autofocus setup was established individually for both hair follicles according to the 
following procedure: by visually focusing on the sample, a z-value of 0 µm was 
assigned to the lowest point of the sample (glass cover-slide), then the z-value of the 
highest point of the sample was obtained (normally placed on the hair). Thereby, the 
setup range for the autofocus was established, which was scanned in 1 µm steps for 
the surface determination in both mappings.  
Reference components spectra  
The CLS and MCR-ALS methods (briefly explained in section 1.2.4) use reference 
spectra of pure substances to determine the distribution of the compound in the hair 
follicle. The non-treated cryosections were employed to obtain reference spectra of 
Stratum Corneum (SC), epidermis, dermis, glass substrate, Cryospray drops and 
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caffeine, which proved to result in high sensitivity. Franzen et al.[95] used reference 
spectra of Sebum, Epidermis, Dermis and hair. The reference spectrum of the active 
was obtained by measurements of the pure compound. 
Except for the five times increased accumulation time, all the reference measurements 
were performed on the same settings, as employed for the mapping acquisition. 
Data Analysis 
All spectra were pre-processed using the Labspec software. After cosmic spike 
removal, a polynomial fit was used to subtract the fluorescence background. In order 
to evaluate the distribution of caffeine in the hair follicle, the following methods were 
employed. 
The peak fitting module is integrated in the Labspec software. The caffeine-based 
Raman peak at 555 cm
-1
 was approximated using non-linear regression of a Gaussian 
function. This peak was chosen for analysis due to its prominence in caffeine and the 
minor overlapping with the main skin Raman bands. For each measured position, the 
peak amplitude at 555 cm
-1 
was plotted as a false color intensity image overlaid on the 
microscopic image. 
The CLS fitting section of the Labspec software was used to perform multivariate CLS 
regression on the multidimensional array of spectra using a set of reference 
component spectra (caffeine, Stratum Corneum, epidermis, dermis, hair, glass and 
cryospray). The scores and the reference spectra were normalized and restricted to 
non-negativity. Finally, all scores of the different component were plotted in false color 
intensity images, overlain on the microscopic images. As each Raman spectrum is a 
fingerprint of the chemical composition of the sample, the distribution of different 
substances can be analyzed. Using the reference spectra of the substances, the relative 
contribution of the reference spectra at each measurement point is calculated. By 
assigning the spectrum of each chemical substance to a color, the distribution of all the 
reference spectra within the examined section can be indicated giving a color coded 
image of the scanned area.  
The recorded spectra were also analyzed using the MCR-ALS algorithm. This was 
implemented in self programmed software based on Matlab R2016a (the MathWorks, 
Inc., Natick, MA, USA) and incorporated the graphical user interface MCR-ALS GUI 2.0 
developed by Tauler et al.[96] Reference spectra of seven different components were 
applied to the analyses as initial estimates (caffeine, Startum Corneum, epidermis, 
dermis, glass and cryospray). The only constraint applied for the optimization process 
was non-negativity of the resolved scores and loadings. Semi-quantitative parameters 
were calculated from the scores by dividing the caffeine score by the sum of all scores 
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for every measured position, according to Vajna et al. [97] The final scores for caffeine 
were plotted superimposed in red to the microscopic image.  
4.8. Infrared spectroscopy 
Two techniques based on the Fourier transform infrared (FTIR) spectroscopy (Figure 
13) are used in this doctoral thesis. From one side, attenuated total reflection in 
conjuction with a FTIR (ATR-FTIR) was used to evaluate the lipidic conformation. On 
the other side, a synchrotron-based Fourier transform infrared microspectroscope was 
used in a similar way than CRM in section 4.7.2 to acquire FTIR spectra in the x-y axis in 
a skin cross section. 
 
Figure 13 A. Spectra acquisition in ATR-FTIR. B. Scheme of the µFTIR: synchrotron light 
(red line) irradiates the sample (in blue); each analyzed position means one spectra; 
combining the spectral information with the spatial information, 2D images can be 
created. Figure is adapted from Franzen et al. [94] 
4.8.1. Evaluation of the lipidic conformation of lanolin synthetic membranes 
by ATR-FTIR 
Lipidic conformation can be studied with ATR-FTIR (Figure 13A). The infrared spectra 
were obtained using the 360-FTIR spectrophotometer Nicolet Avatar (Nicolet 
Instruments, Inc., Madison, WI) equipped with an attenuated total reflection (ATR) 
accessory that used a diamond with an angle of incidence of 45° in a horizontal 
orientation. 
Before analysis, the samples were placed with the SC/lanolin side facing the ATR 




of 10 kPa was applied to the samples. All analyzed spectra represented an average of 
32 scans obtained with a resolution of 4 cm
−1
, and the wavenumber range used was 
4000–700 cm
−1
. The peak positions were determined with the aid of OMNIC software 
version 7.3 (Nicolet, Madison, WI) using a Gaussian-Lorentzian peak fitting and 
baselined spectra. Two different peaks were studied: 2850 cm
−1
 and 2920 cm
−1
, which 
are assigned to the CH2 symmetric and asymmetric stretching vibration, respectively. 
Analysis of every sample was made in triplicate. 
4.8.2. Imaging of skin cross-sections with Synchrotron-Based Fourier 
Transform Infrared microspectroscopy 
Synchrotron-Based Fourier Transform Infrared microspectroscopy (µFTIR) can be used 
to map skin cryosections (Figure 13B). When a sample area is analyzed, many 
measurements in each map position are performed. Each position means one 
spectrum. By combining the spatial information with the spectral information 2D 
images can be created.  
µFTIR sample preparation 
The same day of slaughter, 10µL/cm
2
 of substance were applied and gently spread 
over the skin surface (treated skin section)(section 3.1). The incubation of the skin was 
performed at room temperature (20-25ºC) on a Petri plate with wet paper filter to 
avoid drying of the skin. After 30min of exposure, a biopsy from the treated area 
covered with aluminum foil to avoid interferences was embedded in CRYO-M-BED 
(Bright, UK), frozen in nitrogen liquid and stored at -30ºC. For the preparation of the 
non-treated samples (Blank skin section), a biopsy of skin was taken and then treated 
as explained for the PG sample. The day before the FTIR analysis, the skin blocks were 
cut at 6µm thickness and mounted in a CaF2 window. 
µFTIR experiments 
Synchrotron-Based Fourier Transform Infrared microspectroscopy was performed at 
the MIRAS beamline at ALBA synchrotron (Cerdanyola del Vallès, Spain)[98].  CaF2 
windows containing the cross-sections  were placed in a Hyperion 3000 microscope 
(Bruker, USA) coupled to Vertex 70 spectrometer (Bruker, USA). The employed 
detector was a 50 µm HgCdTe (MCT) Detector (10000-600 cm
-1
). 
The infrared spectra were acquired at room temperature in transmission mode. The 
data were recorded using an aperture size of 10 µm x 10 µm. Spectra were collected in 
the 4000–800 cm
-1
 mid-infrared range at a spectral resolution of 4 cm
-1 
with 128 co-
added scans per spectrum. 
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µFTIR data treatment and statistical analysis 
To extract spectral information, the OPUS software (Bruker, USA) was used.  The 
obtained data was processed as follows: the spectra with higher intensities than 1.5 
cm
-1 
were excluded for the calculations due to the lack of spectral quality and the 
presence of saturated regions. Then each spectra was manually grouped considering in 
which layer was acquired (epidermis or dermis) and if it was untreated (NT) or treated 
with propylene glycol (PG).  
The peak positions were determined with the aid of OMNIC software version 7.3 
(Nicolet, Madison, WI) using a Gaussian-Lorentzian peak fitting after baseline and 
normalization. Analysis of every spectrum was made and the average and the standard 
deviations calculated in every sample.  
To compare the different spectra groups the principal component analysis (PCA) was 
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5. RESULTS AND DISCUSSION 
5.1. Comparative study between in silico and in vitro models for 
prediction the permeability of topical actives  
In this section, the permeability of topical active agents with very different physico-
chemical properties was investigated with different methodologies. Three in silico 
models (Potts and Guy, Mitragotri and Barratt) and two in vitro models (skin-PAMPA 
and Franz cells) were applied to determine percutaneous absorption profiles. 
Permeability in Franz cells was determined for compounds formulated in propylene 
glycol and for some of the compounds in the commercial formulas to evaluate the 
fundamental vehicle effect. 
As it can be seen on Figure 14 the selected set of actives comprises a wide chemical 
diversity, including: 1 quaternary salt, 1 zwitterion, 5 acids, 5 bases and 11 neutral 
compounds. Following the results of the different applied methodologies are 
discussed.  
 
Figure 14 Selected topical actives with their molecular weight and lipophillicity ranked 
according their chemical nature 
5.1.1. In silico skin permeability models (QSPR)  
The physico-chemical properties of the actives were determined to be applied to the 
three selected in silico models from Table II (section 4.1).  
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The obtained physicochemical properties are compiled in Table V. All three models 
take into account the lipophilicity as the main parameter of the active. It must be kept 
in mind that the lipophilicity of a substance can be influenced by the pH of the 
environment. For this reason, the octanol-water distribution coefficients (log 𝐷) were 
determined at pH 5.5 (pH of Stratum Corneum from skin). The different models also 
take into account other properties of the actives, such as molecular weight, molecular 
volume and melting point. 
Table V Theoretical physico-chemical properties. Molecular weight (MW), Molecular 
volume (MV), Melting point (MP), Octanol-water distribution coefficients (𝐥𝐨𝐠 𝑫) at pH 
5.5. 
Name MW MV MP (ºC) 
𝐥𝐨𝐠 𝑫 
pH 5.5 
Azelaci acid (Aze) 188.22 162.92 110 -0.16 
Betamethasone dipropionate (Bet) 504.59 411.59 187 3.96 
Bexarotene (Bex) 348.48 307.32 225 5.5 
Calcipotriol monohydrate (Cal) 412.61 372.49 114 3.84 
Clindamycin phosphate (Cli) 424.98 350.54 108 -1 
Clobetasol propionate (Clo) 466.97 367.35 199 4.18 
Dapsone (Dap) 248.3 180.41 173 1.27 
Diclofenac sodium (Dic) 296.15 212.31 276 2.75 
Diphenidramine (Dip) 255.36 225 171 0.52 
Eflornithine (Efl) 182.17 140.97 241 -4.66 
Finasteride (Fin) 372.54 327.9 258 3.07 
Fluorouracil (Fo) 130.08 84.37 285 -0.66 
Flurandrenolide (Fra) 436.51 355.69 215.5 1.56 
Glycopirrolate (Gly) 318.43 274.74 194 -1.41 
Imiquimod (Imi) 240.3 203.05 301 2.4 
Ketoconazole (Ket) 531.43 405.76 151 3.65 
Lidocaine (Lid) 234.34 214.37 69 0.61 
Nicotine (Nic) 162.23 143.03 91 -1.96 
Salicylic acid (Sal) 138.12 100.49 161 -0.67 
Tacrolimus (Tac) 804.02 692.51 129 5.59 
Tazarotene (Taz) 351.46 290.17 104 5.22 
Terbinafine (Ter) 291.43 269.25 42 2.36 
Tofacitinib (Tof) 312.37 252.79 113.7 -0.25 
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These physico-chemical properties showed that the selected actives cover a wide 
range of molecular weight between 130.08 g/mol for fluorouracil and 804.02 g/mol for 
tacrolimus. As the molecular volume value is closely related to the molecular weight, a 
wide range of molecular volumes was also obtained. Additionally, a wide spectrum of 
melting points was observed. The range of the melting points fluctuates between 42ºC 
(terbinafine) and 301ºC (imiquimod).   
Additionally, a vast range of lipophilicities was obtained. The lower distribution 
coefficients are the ones for eflornithine, indicating the most hydrophilic compound, 
whereas the maximum values for the distribution coefficients are for bexarotene and 
tacrolimus, as the most hydrophobic compounds.  
Mathematical models that consider different physico-chemical properties are able to 
predict the skin permeability constant (log 𝐾𝑝). Values of the different properties of 
the chosen topical actives were obtained. Then, the three selected models (Potts and 
Guy, Mitragotri and Barratt) were applied, and three permeability constants per active 
were obtained (Table VI). It should be kept in mind that the skin surface pH is 
approximately 5.5; for this reason, the log 𝐷 at this pH was employed in the three 
models. 
The mathematical equations of the three models are quite similar, especially between 
the Mitragotri and the Potts and Guy models. The first terms of the three equations 
have a linear relationship between them. The lipophilicity is multiplied for a factor 
from 0.7-0.82 in all equations. The second terms of the three equations refer to the 
“molecular size” effect represented as the molecular weight (Mitragotri and Potts and 
Guy) or the molecular volume (Barratt). Even though their values are different, the 
second terms for the three models have a strong linear correlation in our subset of 
actives. However, the Barratt equation includes the melting point value, which is 
responsible for the main differences between models. 
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Table VI in silico Log 𝑲𝒑 (cm/s) predictions using Mitragotri (Mi), Potts and Guy (P-G) and 
Barratt (Bar) models applying 𝐥𝐨𝐠 𝑫 at pH 5.5. In vitro log Pe  values using Skin-PAMPA in 
buffer (pH 5.5) and in PG. 
 in silico QSPR models 
 Log 𝑲𝒑  (cm/s) 
Mi 
Log 𝑲𝒑 (cm/s) 
P-G 
Log 𝑲𝒑 (cm/s) 
Bar 
Azelaci acid (Aze) -7.74 -7.56 -8.31 
Betamethasone dipropionate (Bet) -7.05 -6.56 -10.23 
Bexarotene (Bex) -4.98 -4.52 -9.47 
Calcipotriol monohydrate (Cal) -6.56 -6.09 -7.13 
Clindamycin phosphate (Cli) -10.03 -9.60 -10.67 
Clobetasol propionate (Clo) -6.67 -6.18 -10.11 
Dapsone (Dap) -7.22 -6.91 -9.74 
Diclofenac sodium (Dic) -6.54 -6.16 -12.85 
Diphenidramine (Dip) -7.79 -7.49 -10.69 
Eflornithine (Efl) -10.83 -10.72 -16.90 
Finasteride (Fin) -6.84 -6.39 -12.93 
Fluorouracil (Fo) -7.57 -7.56 -14.82 
Flurandrenolide (Fra) -8.31 -7.85 -12.79 
Glycopirrolate (Gly) -9.60 -9.24 -13.64 
Imiquimod (Imi) -6.36 -6.06 -14.02 
Ketoconazole (Ket) -7.43 -6.95 -9.04 
Lidocaine (Lid) -7.57 -7.30 -6.53 
Nicotine (Nic) -8.77 -8.68 -8.86 
Salicylic acid (Sal) -7.65 -7.62 -10.14 
Tacrolimus (Tac) -7.58 -7.23 -9.26 
Tazarotene (Taz) -5.19 -4.74 -4.85 
Terbinafine (Ter) -6.78 -6.40 -4.58 
Tofacitinib (Tof) -8.75 -8.38 -9.35 
 
In general, lower Kp values were obtained in the Barratt model, whereas the Potts and 
Guy and Mitragotri models present very similar values. Log Kp values obtained with 
the different models of the different compounds are represented in Figure 15.  
A linear relationship occurs between the Potts and Guy and Mitragotri models, as 
expected (r
2
=0.99). Both models have the same underlying assumption that the 
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tortuous lipid matrix is the pathway for transdermal permeation and predict skin 
permeability from the lipophilicity and the molecular weight. Even though the 
relationship between the Barratt values and the Potts and Guy values has a slope close 
to 1, the values are very dispersed, obtaining a regression factor of only 0.213. Much 
higher permeability was obtained for lidocaine and terbinafine with low melting points 
and lower permeability for diclofenac, eflornithine, finasteride, fluorouracil, 
flurandrenolide and imiquimod, all with melting points higher than 240ºC. On the 
other hand, all the models predicted the highest permeability for tazarotene and the 
poorest permeability for eflornithine. Their degrees of permeability are mainly due to 
their lipophilic properties. 










































































































Figure 15 Linear correlation of LogKp obtained with Potts and Guy against Mitragotri’s 
(black dots and solid line) and Barratt’s (gray cross and discontinuous line) permeability 
constants. 
5.1.2. In vitro skin permeability models 
Two in vitro skin permeability models have been applied in the present work using 
synthetic membranes (skin-PAMPA, detailed in section 4.2) or pig excised skin (section 
3.1) mounted in Franz cells (detailed in section 4.3) 
RESULTS AND DISCUSSION 
70 
5.1.2.1. Permeabilities of topical actives studied with skin-PAMPA 
The actives selected with the QSPR models (Table V) were also studied with the skin-
PAMPA methodologies. Actives were all formulated in propylene glycol and in a buffer 
solution at pH 5.5 (section 4.2). Permeation assay was performed following the 
amounts in each compartment were obtained with UPLC-MS/MS (section 4.6.2), the 𝑃𝑒 
was calculated following the procedure detailed by Ottaviani et al. [60]. 
The 𝑃𝑒 gives us information about the intrinsic facility of each compound for diffusing 
across the PAMPA membrane. The results in both experiments (PG and buffer 5.5) are 
compiled in n Table VII. 
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Table VII Skin-PAMPA log Pe values (cm/s) for buffer and PG 
 Skin-PAMPA (Buffer pH5.5) Skin-PAMPA (PG) 
 log Pe (cm/s) log Pe (cm/s) 
Azelaci acid (Aze) -7.28 -6.7 
Betamethasone dipropionate (Bet) -5.98 -7.7 
Bexarotene (Bex) -5.4 -7.7 
Calcipotriol monohydrate (Cal) -5.6 -8.8 
Clindamycin phosphate (Cli) -9.07 -7.6 
Clobetasol propionate (Clo) -5.64 -7.6 
Dapsone (Dap) -6.5 -8.9 
Diclofenac sodium (Dic) -4.39 -7.3 
Diphenidramine (Dip) -8.07 -7.2 
Eflornithine (Efl) -7.09 -6.9 
Finasteride (Fin) -6.17 -7.3 
Fluorouracil (Fo) -6.73 -5.2 
Flurandrenolide (Fra) -6.2 -7.4 
Glycopirrolate (Gly) -9.29 -8.2 
Imiquimod (Imi) -9.34 -8.1 
Ketoconazole (Ket) -6.24 -9.3 
Lidocaine (Lid) -6.07 -6.3 
Nicotine (Nic) -7.02 -7.5 
Salicylic acid (Sal) -6.5 -7.2 
Tacrolimus (Tac) -9.71 -8.9 
Tazarotene (Taz) -8.63 -9.3 
Terbinafine (Ter) -6.93 -9.1 
Tofacitinib (Tof) -7.3 -7.4 
 
The results showed the high influence of the vehicle on the distribution across the 
PAMPA membrane. In Figure 16, the different actives are labelled considering their log 
Pe: high permeability in green (log Pe <-6), medium permeability in yellow (log Pe 
between -6 and -8) and low permeability in red (log Pe >-8). When the buffer at pH 5.5 
was employed, our set of actives showed a high rank of permeability constants (-10 to 
-5) (solid pattern in Figure 16). In contrast, when the substances were vehiculazed in 
propylene glycol, the permeability constants ranged from -9 to -7 (dotted pattern in 
Figure 16). The substances with a high permeability in the buffer solution reduced their 
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permeability when the propylene glycol was employed, whereas the opposite effect 
was observed in the actives with lower permeability constants in the buffer. This effect 
could be due to the influence of the propylene glycol by diminishing the barrier 
properties of the membrane which may modulate the active permeabilities. The 
influence of propylene glycol on the skin structure will be studied in depth on section 
5.1.5. 
 
Figure 16 Skin-PAMPA log Pe (cm/s) values in buffer solution at pH 5.5 (solid pattern) and 
in propylene glycol solution (dotted pattern). Actives are classified in high (green), 
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5.1.2.2. Permeability and skin absorption of topical actives by Franz 
diffusion cells 
Then, another in vitro assay was performed to study the prediction helpfulness of the 
in silico models. Franz diffusion cell (section 1.2.2.1) with dermatomed porcine skin 
was employed following the corresponding method described in section 4.3 for 
percutaneous absorption determination. 
The use of Franz diffusion cells makes possible to determine the actual amount of drug 
that diffuses across the skin. The distribution in the various skin compartments and in 
the receptor fluid, mimicking the systemic compartment of the selected compounds 
was determined by UPLC-MS/MS (section 4.6.2). Moreover, the effect of the 
commercial vehicle comparing the penetration profiles in propylene glycol versus the 
respective commercial cream will be discussed. 
Therefore, this in vitro system has been used to compare the skin penetration profiles 
of each compound in different formulations, PG solutions, and some of their 
corresponding commercial creams (Table VIII).  
Table VIII Formulations, concentration, manufacturer and abbreviation used in the Franz 
cell assays.  
 Formulation  Concentration Formulation manufacturer Abreviation 
Bet 
Betamethasone dipropionate PG Sol.  0.5 mg/g Self-prepared Bet-PG 
Diproderm® cream  0.5 mg/g MSD Bet-cre 
Clo 
Clobetasol PG Sol.  0.5 mg/g Self-prepared Clo-PG 
Clovate® cream  0.5 mg/g IFC Clo-cre 
Fo 
Fluorouracil PG Sol. 50 mg/g Self-prepared Fo-PG 
Efudix® cream 50 mg/g Meda Pharmaceuticals Ltd. Fo-cre 
Fra Flurandrenolide PG Sol. 0.5 mg/g Self-prepared Fra-PG 
Gly Glycopirrolate PG Sol.  5 mg/g Self-prepared Gly-PG 
Ket 
 Ketoconazole PG Sol. 20 mg/g Self-prepared Ket-PG 
Fungarest® crema  20 mg/g Janssen, Belgium Ket-cre 
Lid 
Lidocaine PG Sol. 20 mg/g Self-prepared Lid-PG 
Dermovagisil® cream  20 mg/g Laleham health, UK Lid-cre 
Tac Tacrolimus PG Sol. 1 mg/g Self-prepared Tac-PG 
Taz Tazarotene PG Sol. 1 mg/g Self-prepared Taz-PG 
Tof Tofacitinib PG Sol.  10 mg/g Self-prepared Tof-PG 
 
The retention of the actives in the skin was first evaluated from solution in a pure 
solvent, such as propylene glycol, with the objective to keep the formulation as simple 
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as possible, having in mind that PG is a solvent used in many topic formulations, and 
that it is able to solubilize most compounds. Moreover, to avoid permeability 
differences caused by concentration, the propylene glycol solutions were formulated 
at the same concentration as the corresponding commercial formulation for most of 
the employed actives. This, however, implies in some cases that different amounts of 
different actives were applied; moreover, the important drag effect caused by the 
active saturation degree in each formulation was not considered. It is also important to 
remark that the receptor fluid was chosen to be the same for all actives (section 4.3) 
even though the great differences in lipophillicity for all actives. Despite the addition of 
bovine serum albumin, the capacity of the receptor fluid to solve lipophillic 
compounds may play an important role to explain permeability differences between 
the tested actives. 
The resulting recovery was acceptable (100±25%) for all the tested formulas. The 
compounds were recovered from the skin surface (W), Stratum Corneum (SC), 
epidermis (E), dermis (D) and receptor fluid (RF)(Table IX). The concentrations retained 
by the SC were not absorbed by the skin and did not contribute to the systemic dose. 
However, the concentrations found in the epidermis and dermis could be absorbed 
and reach the systemic level[46]. Therefore, the amount of percutaneous absorption 
(ABS) is normally assumed to be the sum of the concentrations in the epidermis, 
dermis and receptor fluid. Moreover for many of the selected actives their receptors 
are located in the epidermis and the dermis tissue (E+D), so the amounts founded in 
such layers are important to know. The amounts of actives in every layer are 
represented in  Table IX and Figure 17 for the actives formulated in propylene glycol 
(PG) and in Table X  and Figure 18 for the commercial creams. To better compare the 
different formulations, the absorbed amounts are compiled in Table XI. 
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Table IX Distribution of compounds in pig skin expressed as % of substance for each 
sample: surface excess (W), Stratum Corneum (SC), epidermis (E), dermis (D) receptor 




W (%) SC (%) E (%) D (%) RF (%) D+E (%) ABS (%) 
Bet- PG 0.5 88.36±3.90 5.24±1.87 3.87±1.34 0.56±0.43 1.96±1.38 4.43 6.39 
Clo-PG 0.5   88.12±1.75 5.00±2.75 3.79±1.60 2.39±1.81 0.71±0.41 6.18 6.89 
Fo-PG 50   83.73±3.08 10.41±2.81 4.22±1.82 0.78±0.47 0.86±0.75 5.00 5.86 
Ket-PG  20    91.66±2.15 3.25±1.74 3.32±1.23 0.63±0.39 0.50±0.13 3.95 4.45 
Lid-PG  20   32.36±10.79 4.28±1.04 1.01±0.57 2.32±0.45 60.02±10.64 3.33 63.35 
Fra-PG  0.5   89.99±4.06 4.25±2.14 1.94±0.61 1.33±1.85 1.64±2.31 3.27 4.91 
Gly-PG  5   77.12±3.59 7.51±3.79 7.27±2.12 2.04±2.12 4.56±2.45 9.31 13.87 
Tac- PG  1   77.51±5.51 13.40±1.57 6.37±1.56 1.76±0.56 0.96±0.40 8.13 9.09 
Taz-PG 1   94.85±1.20 2.48±0.84 1.37±0.86 0.99±0.59 0.31±0.12 2.36 2.67 
Tof-PG 10   71.00±6.00 19.2±4.3 7.2±2.8 2.1±0.81 0.25±0.32 9.3 9.55 
 
 
Percutaneous absorption of the 10 evaluated actives in PG shows a similar behavior, 
the active is distributed following the order W>SC>E>D. To sum up our data from the 
PG solutions, a relation between a high retention in W and less permeation was found 
for most of the actives. The compounds were found to have a reduced distribution 
when going in depth through the skin.  
As it can be seen, Taz is highly found in the W and partially retained in the SC; 
therefore, it is the lowest absorbed compound (Table XI). Although the absorption 
behavior of Taz differs from the skin permeation predicted by its physical-chemical 
properties, others authors demonstrated its limitation of percutaneous absorption 
when Taz was topically applied [99].  
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Figure 17 Cumulative amounts (%) found in the Stratum Corneum (SC), epidermis (E), 
dermis (D) and receptor fluid (RF). 
 
Bet, Clo, Fo, Ket and Fra are compounds with medium permeabilities (from 4.45% to 
6.89%) when they are formulated in PG. The results also show that low amounts of 
substance are found in the W for Gly, Tac and Tof, but at the same time, they show 
high retention in the SC. These three substances are also more retained in the 
subsequent skin layer (E) than the rest of the compounds. As a consequence, Gly, Tac 
and Tof have high percutaneous absorption (Table X). 
Surprisingly, Lid presents a different profile. The compound is scarcely retained in the 
W and SC, but that it is mainly detected in the receptor fluid (60%). Moreover, when 
the E and D layers are observed, more lidocaine is found in D than in E, whereas in all 
the other PG solutions, the amounts obtained in E are always higher than those in D. 
Lidocaine is a basic molecule with a hydrophilic value at pH 5.5 but this changes to 
lipophilic at pH 7 due to its pKa[100]. The pH gradient at the SC depth and the change 
of hydrophilic to lipophilic property of Lid may influence its high diffusion. 
Commercial creams of 5 of these actives were also evaluated with the Franz cell assay. 
In general, most of the other creams maintain the compound distribution explained 
before for PG solutions (W>SC>E>D) (Figure 18). The obtained order of the 
percutaneous absorption was Li>Clo>Ket  Bet>Fo (Table XI). 
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Table X Distribution of compounds in pig skin expressed as % of substance for each 
sample: surface excess (W), Stratum Corneum (SC), epidermis (E), dermis (D) receptor 




W (%) SC (%) E (%) D (%) RF (%) D+E (%) ABS (%) 
Bet- cre 0.5  97.32±0.75 1.35±0.76 0.85±0.28 0.35±0.22 0.14±0.12 1.2 1.34 
Clo-cre  0.5  95.91±4.62 0.99±1.64 0.86±0.91 1.17±1.78 0.07±0.02 2.03 2.1 
Fo-cre 50  97.09±0.13 1.42±1.11 0.61±0.21 0.13±0.06 0.04±0.03 0.74 0.78 
Ket-cre 20   94.89±2.26 2.33±2.56 0.62±0.28 0.17±0.06 0.83±0.18 0.79 1.62 
Lid-cre 20  90.55±3.83 3.10±0.38 0.29±0.11 0.66±0.24 5.40±3.67 0.95 6.35 
 
Lidocaine showed a similar distribution when it was applied as a cream. As previously 
detailed, Lid-PG was mainly found in the RF, and in contrast to the other formulations, 
the amounts in D are greater than those in E. Such a situation is also repeated in Lid-
cre; high absorption and dermis accumulation of the compound was detected. 
However, it should be noted that the great diminution of penetration of lidocaine in all 
skin strata is due to an important percutaneous absorption of 6.3%; that is, however, 
ten times lower than the same active in PG. 








Figure 18 Cumulative amounts (%) found in the Stratum Corneum (SC), epidermis (E), 
dermis (D) and receptor fluid (RF). 
The vehicle effect on the compound skin distribution can be compared, considering 
that the PG solutions are formulated at the same concentration as the commercial 
formulations. A common feature for the PG solutions is that in every skin layer (SC, E 
and D), the different actives are much more retained than in creams. This leads to the 
higher absorption observed for PG solutions than creams since the absorbed averages 
are the sum of E, D and RF (Table XI).  
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Table XI Absorbed amounts (%) calculated from the sum of epidermis, dermis and 
receptor fluid normalized amounts. 
Active (concentration) PG solutions Creams 
Betamethasone dipropionate (0.5 mg/g) 6.39 1.34 
Clobetasol propionate (0.5 mg/g) 6.89 2.1 
Fluorouracil (50 mg/g) 5.86 0.78 
Ketoconazole (20  mg/g) 4.45 1.62 
Lidocaine (20  mg/g) 63.35 6.35 
Flurandrenolida (0.5 mg/g) 4.91 - 
Glycopyrrolate (5 mg/g) 13.87 - 
Tacrolimus (1 mg/g) 9.09 - 
Tazarotene (1 mg/g) 2.67 - 
Tofacitinib (10 mg/g) 9.55 - 
 
Summarizing the effect of the vehicles studied , it can be concluded that PG solutions 
show, in general, the highest amounts in all the different layers of the skin (SC, E, D), 
and that the observed compound distribution (W>SC>E>D) is generally maintained in 
PG and cream formulations.  The observed enhancer effect of PG in the skin has been 
widely described [101]. In this thesis an additional study based on the effect of PG on 
the skin lipids by IR has been performed (section 5.1.5). It must be noted that our 
study does not consider the effect of the compound saturation degree in its 
formulation and that the steady state of the system cannot be assumed after 24 h of 
exposition in all the formulations. 
5.1.3. Correlations between models 
In silico vs skin-PAMPA 
One of the objectives of this work was to study the relationship between the different 
predictive assays of topical exposure.  Log Pe by skin-PAMPA of all compounds at pH 
5.5 and in PG were related to the Log Kp obtained with the three models applying 
log 𝐷 at pH 5.5. Linear correlations between the two Pampa lists of values and the 
three in silico models were very low. The best correlation was found between Potts 
and Guy and Mitragotri models with skin-PAMPA values at pH 5.5 with slopes of 
approximately 0.4 and correlation coefficients of approximately 0.1 (Figure 19). 
Therefore, a very poor linear correlation was found between this in vitro model with 
the three in silico models for the actives studied. 
Most of the studies carried out to obtain the in vitro models present a log 𝐾𝑝 deducted 
from more than 50 actives, and the linear regression is obtained from bulk data in 
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which the individual actives do not always match[102]. In the present work, only 23 
actives were studied, and in Figure 19, it is clear that several compounds give different 
results using the in silico methodology rather than the skin-PAMPA. In particular, 
compounds with marked hydrophobic character, such as bexarotene, imiquimod, 
tacrolimus, and specially, tazarotene, present a lower permeation than the one 
expected by the in silico models. In contrast, eflornithine, the most hydrophilic 
compound assayed, presents higher permeation than expected by the models. 















































































Figure 19 Linear correlation of log Pe (cm/s) from the skin-PAMPA assay at pH 5.5 against 
𝐥𝐨𝐠 𝑲𝒑 (cm/s) obtained by the Potts and Guy and Mitragotri model. 
Skin-PAMPA vs Franz diffusion cells 
The Franz data were also correlated with the ones obtained by skin-PAMPA. It is 
important to have in mind that results obtained for the Franz cells account only for 10 
actives when formulated in PG and 5 actives in creams. When the Franz cell data are 
compared against the skin-PAMPA also low correlations are obtained in our set of 
actives. However, the permeability constant from the PAMPA assay at pH 5.5 was 
better compared with the percutaneous absorption obtained with Franz cell assays of 
the actives in creams (Figure 20). Even though a low correlation coefficient is observed 
when related to percutaneous absorption, it increases when correlated with E+D 
amount. Lid shows a high absorption due to its high amounts found in the RF. 
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Therefore, when the log Pe skin-PAMPA pH 5.5 is compared with E+D without RF, the 
correlation factor increases.  
 

















































Figure 20 Linear correlation of log Pe (cm/s) from the skin-PAMPA assay at pH 5.5 against 
log Kp (cm/s) obtained by the Potts and Guy and Mitragotri model. 
The results obtained in this work underline the role of the formulation in skin 
penetration and retention of compounds. It was found that skin uptake of a drug is 
strictly related to solvent uptake, suggesting the relevance of the solvent drag effect in 
skin delivery for the tested actives. Then, the effect of vehicles on skin penetration has 
been studied in more detail in the next section 5.1.4. 
 
Sumarizing sections 5.1.1, 5.1.2 and 5.1.3. A comparative study of percutaneous 
absorption with Franz diffusion cells with propylene glycol solutions and some of their 
commercial creams was presented. Higher absorption rates were observed in the 
propylene glycol solutions compared with the cream formulas, due to the widely 
reported enhancer effect of propylene glycol. The fundamental effect of the vehicle in 
the permeability of topical actives is apparent. 
The results of the skin-PAMPA assay at pH 5.5 and the amount of the compound in the 
epidermis and dermis of the Franz cell data of the cream formulations were better 
correlated. This correlation indicates the effectiveness of the two in vitro assays at 
assessing the formulation and the detrimental effect of PG on the skin or on the 
membrane with lipids from skin. Mathematical models and in vitro models are good 
prediction methodologies to determine permeation for some but not all topical 
actives. Franz cell diffusion permeation is important not only to determine total 
permeation but also to settle the amounts of actives in each skin layer, which is 
fundamental for topical skin treatments. 
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A research paper entitled “Comparative study between in silico and in vitro models for 
predicting the permeability of topical actives” based on the results of sections 5.1.1, 
5.1.2 and 5.1.3 is at the moment under preparation 
 
5.1.4. Effect of vehicle on skin penetration  
Glucocorticoids (GCs) are actives widely used in the treatment of skin diseases. The 
efficacies of topical GCs are linked to their availability to reach their receptors. The 
affinity between the receptor and the steroid as well as its cellular uptake and 
residence time, determines the clinical effect[103–105]. All these processes are highly 
influenced by the physicochemical properties of the drug as well as the 
vehicle[65,106–109]. Moreover steroids potency can also differ depending on the 
vehicle in which they are formulated. Hence, to modulate their effects they are 
available in a wide range of preparations including gels, creams, ointments, foams, 
lotions, oils and sprays[110].  
The aim of this section is to study the relationship between the skin absorption, the 
substance lipophilicity and the effect of the vehicle of glucocorticoids. Therefore, a 
study is presented using the static diffusion cells of betamethasone dipropionate (Bet), 
clobetasol propionate (Clo) and flurandrenolide (Fra). Three different vehicles are 
assayed including commercial creams, their respective ointments and propylene glycol 
solutions (Table XII). The three compounds are all formulated at the same 
concentration as in their commercial formulations.  
Table XII Formulations, concentration, manufacturer and abbreviation used in the Franz 
cells assay 
 Formulation  
Conc. 
(mg/g) 
Formulation manufacturer Abreviation 
Bet 
Betamethasone dipropionate PG Sol.  0.5   Self-prepared Bet-PG 
Diproderm® cream  0.5   MSD Bet-cre 
Diproderm® ointment 0.5   MSD Bet-oin 
Clo 
Clobetasol PG Sol.  0.5   Self-prepared Clo-PG 
Clovate® cream  0.5   IFC Clo-cre 
Declobán® ointment  0.5   Teofarma Clo-oin 
Fra 
Flurandrenolide PG  0.5   Self-prepared Fra-PG 
Cordran® SP Cream 0.5   Oclassen Pharmaceuticals Inc Fra-cre 
Cordran® SP ointment 0.5   Oclassen Pharmaceuticals Inc Fra-oin 
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It should be noted that although each formulation has the same concentration of the 
active ingredient, each formulation will have a different degree of saturation in each 
vehicle, which highly influences the absorption of substances through the skin[111]. 
One of the important parameters that influences the high affinity of a GC for its 
receptor (and therefore its glucocorticoid effect) is the lipophilicity of the molecule 
which are compiled in Table V for the three actives.  Fra is the least potent of the 
selected drugs, which is in accordance with its low log 𝐷 value. In the cases of Bet and 
Clo, it has to be considered that betamethasone dipropionate is a prodrug of the free 
form, betamethasone. After topical administration, the drug is hydrolysed by esterase 
enzymes primarily in the skin. Then, after the hydrolysis of the molecule, the 
lipophilicity and log D values are much lower. Therefore, the most potent substance 
(Clo) has the highest log D value. 
Besides the affinity of a substance for its receptor, the efficacy of a topically applied 
substance is linked to its availability to contact the target/receptor. Glucocorticoid 
receptors are known to be located in epidermal and dermal cells[103,112]. Therefore, 
in Table XIII, in addition to the compound distribution in the different layers, the 
amount of compound in E+D and the percutaneous absorption (E+D+RF) are also 
described. 
In general, the three compounds in all of the formulations have a common penetration 
profile, in which the amount of substance found in each layer decreased when 
increasing in depth (SC>E>D). Only Clo-oin and Clo-cre have similar amounts in all 
three skin strata. The amount found in the receptor fluid is clearly dependent not only 
on the substance but also on the vehicle.  
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Table XIII Distribution of compounds in pig skin expressed in µg and % for each sample: 
surface excess (W), Stratum Corneum (SC), epidermis (E), dermis (D), receptor fluid (RF), 
and the total amount in µg 
    W (%) SC (%) E (%) D (%) RF (%) D+E (%) ABS (%) 
 
Bet- PG 88.85 ± 3.90 5.21 ± 1.87 3.78 ± 1.34 0.48 ± 0.43 1.75 ± 1.38 4.26 6.01 
Bet Bet-cre  97.30 ± 0.75 1.43 ± 0.76 0.87 ± 0.28 0.33 ± 0.22 0.13 ± 0.12 1.2 1.33 
  Bet-oin  96.32 ± 0.70 2.06 ± 0.32 0.95 ± 0.39 0.49 ± 0.12 0.18 ± 0.13 1.43 1.61 
 
Clo-PG 88.12 ± 1.75 4.94 ± 2.75 3.84 ± 1.60 2.39 ± 1.81 0.71 ± 0.41 6.21 6.91 
Clo Clo-cre  95.91 ± 4.62 0.99 ± 1.64 0.86 ± 0.91 1.17 ± 1.78 0.07 ± 0.02 2.03 2.1 
  Clo-oin   89.72 ± 3.40 2.53 ± 3.10 2.12 ± 0.91 2.65 ± 1.53 3.03 ± 2.08 4.77 7.8 
 
Fra-PG 89.99 ± 4.06 4.25 ± 2.14 1.94 ± 0.61 1.33 ± 1.85 1.64 ± 2.31 3.27 4.91 
Fra Fra-cre  90.98 ± 0.40 1.77 ± 0.02 0.77 ± 0.02 0.69 ± 0.02 5.79 ± 0.22 1.46 7.25 
  Fra-oin  93.08 ± 3.06 1.69 ± 2.16 1.45 ± 0.84 0.80 ± 0.65 1.28 ± 0.17 2.25 3.53 
*ABS is the absorbed amount and represents the sum of E+D+RF 
 
For Bet, when it is applied in PG solution, the amount found in the receptor fluid is 
quite significant, whereas in the cream and ointment, the amount decreases. This is 
probably due to the enhancement effect of PG. Therefore, higher amounts of both E+D 
and E+D+RF for Bet are obtained for the PG formulation.  
Clo has a similar lipophilicity to that of Bet but a lower MW, and it is the most retained 
compound in the E and D as well as in the E+D+RF in all of the employed formulations. 
This higher accumulation of the substance agrees with the higher potency of Clo 
compared to Fra and Bet. The glucocorticoid receptors are located in the E and D, and 
hence, high amounts of Clo in both tissues can lead to a higher efficacy of this 
corticoid.  
Fra is the most hydrophilic compound and showed less affinity for the E and D. For 
example, the three formulations of Fra show higher amounts of the substance in the 
RF than in the upper layer, the D. This is clearly more marked for Fra-cre. This special 
behaviour is consistent in the three formulations and can be explained by the presence 
of the acetonide group in the D ring, which enhances the penetrability and the 
percutaneous absorption of this type of corticoid[113]. In summary, in Clo, Bet and Fra, 
the retention in the tissue (E+D) is always greater when PG is employed. Fra-cre 
contains a high amount of analyte in the RF, which leads to high absorption (E+D+RF) 
with higher systemic exposure. 
Therefore, comparing the drug penetration profiles and their physico-chemical 
properties, it can be concluded that the more hydrophobic compounds (Clo and Bet) 
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are present in higher amounts in the E+D, while the hydrophilic compound (Fra) is 
mostly present in the receptor fluid, which leads to higher percutaneous absorption. 
Additionally, it is important to note the effect of the vehicle. The main components of 
the commercial formulations are water, cetostearyl alcohol and other oily components 
for creams[114–116]and paraffin along with waxes without any water content for 
ointments[117]. Besides, it is important to note that Clo-cre, Clo-oin and Fra-cre also 
contain PG.   
The three compounds showed great differences when they were applied in the 
different formulations, proving that the vehicle is critical in regards to percutaneous 
absorption (Figure 21). Higher amounts of the substance are obtained in the epidermis 
and dermis when ointments are employed compared to creams. This is consistent with 
the general rule that the highest glucocorticoid efficacy is fulfilled with ointments 
compared to creams[118]. This fact is also related to the absence of water content and 
the presence of the waxes and petrolatum of ointments, which is believed to enhance 
the penetration of the substance due to the occlusive effect[119]. In view that oily 
formulations enhance the GC effect/penetration, ointments are mostly used in cases 
of severe dermal diseases and/or on areas with a large SC (such as the palms of the 
hands or soles of the feet).  
On the other hand the enhancement effect of propylene glycol can be discerned. For 
the three PG solutions, the distribution patterns are similar. The SC retains the highest 
amount of substance (about 5%); moreover, the amounts found in the E were also 
higher than with the other vehicles. This is not so clear for the amount in the dermis. It 
could be noted that the PG solutions show the highest amounts of corticoid in the E+D 
when compared with creams and ointments, mainly due to the important amount in 
the E. However, the influence that the degree of saturation may induce in the 
percutaneous absorption of the different vehicles, which has not been considered in 
this work, should be investigated. 
























































































































































Figure 21 Normalized amounts of betamethasone (Bet), clobetasol (Clo), flurandrenolide 
(Fra) applied in different formulations: propylene glycol solutions (PG), ointments (oin) 
and creams (cre).  
Results obtained in sections 5.1.2, 5.1.3 and 5.1.4 indicated the effect of PG acting as 
an enhancer of skin permeation. In the next section the effect of propylene glycol on 
skin modification is studied by ATR-IR to understand this fact. 
 
Summarizing, the influence of PG on the maximum amounts of the analyte in the SC 
and E and similar amounts of the analyte in the D for PG and ointments, with level 
being much lower for creams, should be pointed out. The penetration enhancement 
for Clo-oin and for Fra-cre in the receptor fluid is also observed.  This could be due to 
the presence of PG in these vehicles. 
Since the aim of these glucocorticoids is to act at the E and D, this study confirms the 
higher corticoid efficacy of Clo due to its higher presence in these skin layers. 
Additionally, propylene glycol and the ointments applied induced a higher penetration 
into these layers than the corresponding creams. 
The results compiled in section 5.1.4 are part of a work published in “Drug Testing and 
Analysis”  entitled  “In vitro penetration through the skin layers of topically applied 
glucocorticoids” (Annex 1) 
 
5.1.5. µFTIR study of skin propylene glycol disrruption. 
Propylene glycol (PG) has been used as a common solvent for many drugs in this 
thesis. PG acts changing the solubility of the compound in the formulation, but it may 
also act as a fluidizer of the intercellular lipid matrix, acting as skin enhancer.  
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Non treated skin and skin treated with PG with synchrotron-Based Fourier Transform 
Infrared microspectroscopy (µFTIR)(section 4.8.2) with the aim to study the skin 
alterations when submitted to propylene glycol. Non dermatomed porcine skin was 
cross sectioned and analysed with µFTIR after PG exposure as detailed in section 4.8.2.  
Skin spectrum is displayed in Figure 22. The two strong absorption bands at around 
1650 cm
−1
 (amide I) and 1550 cm
−1
 (amide II) are typical protein bands which arise 
mainly from C-O stretching and N–H bending vibrations, respectively, of amide groups 
of the peptide backbone in proteins[120]. The absorption bands from 3000 to 2800 
cm
−1
 are due to the C–H stretching motions of the alkyl groups present in both proteins 
and lipids. The signal linked to proteins is a broad band, rather weak compared to the 
lipids absorption which exhibits four fine peaks at around 2850 cm
−1
 (CH2 symmetrical 
stretching), 2920 cm
−1
 (CH2 asymmetrical stretching), 2870 cm
−1
 (CH3 symmetrical 
stretching) and 2955 cm
−1
 (CH3 asymmetrical stretching)[121]. A prominent band at 
1745 cm
-1
 related to the C-O stretching band of phospholipids, esters and 
glycerides[122] has been also detected. 
 
 
Figure 22 Baselined FTIR spectrum of skin. Lipidic region (3000-2800 cm
-1
) and the C-O 
stretching band (1745 cm
-1
) are shaded. 
 
Study of the 2800-3000 region 
The Area under the curves (AUCs) were calculated in the 2800-3000 cm
-1
 region in all 
the spectra to study how lipids are distributed in both cryosections (NT and PG). 
Combining the AUC values with the spatial information, the 2D images of the AUC 
distribution were reconstructed (Figure 23). 
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Figure 23 Spatial distibution of area under the curve between (AUC2800-3000) in non-treated 
(NT) and treated with propylene glycol (PG) skin cross sections 
Our data shows that for NT and PG, the AUCs are higher in the right part of the images 
which corresponds to the outermost part of the skin. This agrees with the described 
higher presence of lipids in the Stratum Corneum. Comparison of the NT images are 
compared against the PGs indicates that the treatment of propylene glycol in the skin 
increased the AUCs not only in the outermost region but also in the deeper layers.  
Moreover, the position and the band width of the lipid stretching bands at 2850 and 
2920 are sensitive markers of their chain conformational order (see section 1.1.1.1): 
the increased rotational motion of the alkyl chains during the orthorhombic–hexagonal 
transition and the introduction of gauche defects in the chains during the hexagonal–
liquid transition lead to broadening of the band and its shift to higher wavenumbers. 
To study the position shifts within our samples different studies were performed. 
The spatial information taken with this µFTIR was used to create images of the position 
shifts in the NT and PG samples. With this purpose in mind, the peak fitting method 
(section 1.2.4) was applied at 2850 (νS(CH2)) and at 2920 (νAS(CH2)) positions for all the 
spectral data to detect the respective position shifts.    




Figure 24 Upper images contain 2850 cm
-1
 position variations for blank and PG mapped 
areas. Lower images contain 2920 cm
-1
 position variation for blank and PG mapped areas 
In Figure 24, the increasing position shift at 2850 cm
-1
 and 2920 cm
-1
 after propylene 
glycol treatment can be observed. The NT position values fluctuate between 2850 
(predominant in the outermost region) until 2855 (in the deeper regions) which is in 
accordance with the increasing lipid disorder in the dermis described in other works. 
When PG is applied the position values are mainly at 2855 and in some regions raise 
upon 2858. Moreover after PG treatment no progression of lipid disorder can be so 
clearly observed when going in depth into the skin. Similar information can be 
extracted regarding the position shift at 2920 in both samples. In the Blank values 
between 2923 are predominant in the image and smaller regions with values of 2926 
are observed. The PG treatment clearly increases the position shift to higher values, 
being values between 2926 and 2928 predominant in all the mapped area. 
To specifically study the position shifts in the SC, E and D, the CLS method (section 
1.2.4) was applied. Taking under consideration the microscopic image, one spectrum 
for each skin layer were taken as a reference spectrum and loaded for the CLS score 
calculations.  
The obtained scores, with values from 0 to 100, indicate the similarity between each  
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an image and overlying it with the microscopic image the distribution of each skin layer 
can be distinguished (Figure 25).  
 
  
Figure 25 CLS scores ploted in green (Stratum Corneum), red (epidermis) and blue 
(dermis) for the non treated (NT) and propylene glycol treated (PG) samples.  
In green, the Stratum Corneum is distributed in a narrow area on the outermost part 
of the skin. Epidermis (in red) meant a wider region under the Stratum Corneum. 
Finally, a small portion of the dermis was recognized in both cases (blank and PG) in 
the deepest region of the analyzed area. Both samples seemed to present the three 
layers reasonably distributed if considering the microscopic image. 
Hence, in view that the reference spectra were correctly assigned, the loaded 
reference spectra were analyzed to see their differences and to relate them with 
increased lipid fluidity caused by propylene glycol.  
The position shifts at 2920 and 2850 for all the 6 spectra: Stratum Corneum, epidermis 
and dermis for blank and PG samples; were analyzed using the peak fitting (Figure 26).  
NT PG 
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Figure 26 Classical least squares (CLS) loaded spectra of stratum corneum (green), 
epidermis (red) and dermis (blue) and the positions at 2850 and 2920. 
The results confirmed the shifts to higher values after PG treatment. Both positions 
were sensitive to the PG treatment and also were different between the different skin 
layers. In the three skin layers, when comparing PG against Blank, positions at 2850 
and 2920 increased. Moreover the increasing shifts are observed within each sample 
when going in depth: SC values are lower than E and D. Nevertheless, it is important to 
state that even that the different components were correctly assigned, to have more 
robustness in our results, more spectra should be studied.  
Hence, the spectra of the mapped areas were manually assigned to E or D comparing 
with the microscopic image. After elimination of the spectra with low quality, 69 
spectra were assigned to dermis treated with PG, 95 to epidermis with PG, 72 dermis 
non-treated and  101 to epidermis non-treated. Peak positions at 2850 and 2920 were 
obtained using a gaussian-lorentzian peak fitting in every spectrum. Then, averages 
and standard deviations of every sample were calculated and compiled in Table XIV. It 
is important to remark the increasing frequencies for the two bands at 2850 (νS(CH2)) 
and at 2920 (νAS(CH2)) indicating and increasing disorder of the lipids not only in the 
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Table XIV Peak position at CH2 symmetrical stretching (νS(CH2)) and CH2 asymmetrical 
stretching (νAS(CH2)) and standard deviations of epidermis and dermis in treated  with 




νS(CH2) νAS(CH2) νS(CH2) νAS(CH2) 
Blank 2852.35 ±2.74 2924.44 ±2.96 2852.58 ±3.53 2924.63 ±2.33 
PG  2853.31 ±2.54 2925.36 ±2.28 2854.33 ±2.13 2925.36 ±1.08 
 
We confirmed here the results observed in Figure 26. Increasing frequencies at both 
positions indicate increasing disorder of lipids not only in epidermis but also in the 
dermis after PG treatment. 
C-O stretching band at 1745 cm
-1
 
The peak analyzed at 1745 cm
-1
 corresponding to C-O stretching of lipids seemed to be 
predominant after the PG treatment in dermis and in epidermis. Not much information 
was found in this particular band and the effect that PG may cause. Therefore further 
analysis was performed. 
 
Figure 27 Spatial distibution of area under the curve between 1780-1700 (AUC1780-17000) in 
non treated (NT) and treated with propylene glycol (PG) skin cross sections 
The region between 1780-1700cm
-1
 was baselined and normalized (section 4.8.2). AUC 
for this band are calculated and plotted in Figure 27. Similar distributions than in 
Figure 23 were observed. As this specific band is related with the lipid content and the 
PG exposure, in both cases (NT and PG) the outermost region of the skin contains the 
highest AUC values. NT compared with PG showed that after PG treatment all the AUC 
values increased in all the skin depth. 
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This dataset was also handled by principal component analysis (PCA) for epidermis 
(Figure 28a) and dermis (Figure 28b). This technique is commonly used for data 
classification. It reduces the dimension of the data and extracts only the relevant 
information. The resulting principal components (PCs) represent the variance in the 
data set with decreasing order (PC1 means larger variance than PC2 and so on). The 
scores represent the original data in the new dimensional space spanned by the PCs. 
Hence, when plotting PC-1 against PC-2 the each spectrum is displayed as a score 
which carries information about the sample. 
 
 
Figure 28 Principal component analysis of epidermis (a) and dermis (b) at 1745 cm
-1
. 
Spectra are colored in red (non treated) and blue (PG). Upper part contains the 
representation of PC-1 against PC-2 of all the spectra. The spectra used for the PCA 
calculation are also displayed in the lower part. 
 
In our case, the PC-1 explained more than the 95% of the variation of our data in both 
cases. When representing the PC-1 against the PC-2, in epidermis and dermis it could 
be observed that the treated (blue) and the non-treated (red) groups were clearly 
sorted using the PC-1. This means than in this region we can clearly distinguish 
differences when skin is treated with propylene glycol. This fact can be also observed 
when the spectra of PG and NT samples are displayed together. We could observe that 
the 1745cm
-1
 band was more present after propylene glycol treatment and allowed 
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the differentiation of most of the treated or the non-treated in the epidermis (a) and 
moreover in the dermis (b) spectra. 
 
To sum up the alteration of the barrier function of propylene glycol includes affecting 
bilayer structure of the intercellular lipids. Based on numerous experiments[123], the 
action of solvents such as PG was attributed to a pure cosolvent effect. Maximizing the 
thermodynamic activity of a drug in the vehicle PG contributes to increased drug 
uptake into the skin [124]. However it is unlikely that only one mechanism is 
responsible for the enhancement of drug penetration, particularly for small molecules. 
The present study indicates not only an increase in disorder of lipid in epidermis and 
dermis after treatment with propylene glycol but modification of the C-O band 
attributed to phospholipids, glycerides and esthers in the upper regions of the skin but 
also in depth. 
The work carried in the synchrotron ALBA was possible thanks to a grant from the  
Consortium for the Construction, Equipping and Exploitation of the Synchrotron Light 
Sources (CELLS). 
 
5.2. Design of new lanolin synthetic membranes for in vitro 
methodologies 
Results obtained in section 5.1.3 demonstrate a very poor correlation between 
penetration of actives with different in silico and in vitro models. The key of these 
methodologies is the membrane used to obtain the permeation parameters. 
Therefore, membranes with permeability properties similar to the skin are seek. 
The structure of lanolin, which mimics the lipidic matrix of the SC by having a similar 
chemical composition, may offer a suitable strategy to achieve accurate modeling of 
the skin barrier properties by combination with synthetic membranes. It has been 
demonstrated that lanolin shares some lipidic compounds with the human SC such as 
cholesterol and its derivatives or some free fatty acids[125,126]. The presence of 
ceramides in lanolin fractions was reported[127]. Moreover, other physical properties 
are common such as the presence of lipids in the solid and liquid state at physiological 
temperature[128]. It is important to note that, with the WDS process[88], the resulting 
lanolin has more polar lipids with much human resemblance[129]. 
The main aim of this section is to obtain lanolin-based synthetic membranes to be used 
in skin permeation studies as models of mammalian skin. Lipid structural IR evaluation 
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and water permeation and penetration assays of three topical actives will be 
performed to determine the effect of lanolin on the membrane skin models. 
Lanolin synthetic membranes were formed with Strat-M and Nuclepore membranes 
with lanolin deposition as described in section 4.4. Permeation assays were performed 
to be compared against the original synthetic membranes (Strat-M and Nuclepore) and 
to the skin. 
5.2.1.  Membrane structural properties and permeability to water  
The lipidic conformation for pure lanolin, porcine skin, Nuclepore-lanolin and Strat-M-
lanolin was studied using ATR-FTIR spectroscopy (section 4.8.1). This technique is a 
non-invasive technique with a depth penetration of 1 µm that makes it suitable to 
investigate lanolin or SC without isolation from other layers. For this study, of 
particular interest are the bands associated with the alkyl chain of the lipids. 
Information about the conformational order-disorder of the skin lipids can be 
extracted by the analysis of the 2920 and 2850 cm
-1
 stretching bands. In the case of 




 and 2852 cm
-1
 indicate 
orthorhombic, hexagonal and liquid crystalline, respectively. An increase in the 
vibrational frequency generally indicates an increase in the disorder. A similar behavior 
was observed for the asymmetric CH2 stretching at 2920 cm
-1
, although the symmetric 
stretching is more sensitive to the conformation changes.  
In our case, the peak position in all the replicates was determined, and their average 
and standard deviation were calculated (Table XV). 
Table XV ATR-FTIR of CH2 symmetric and asymmetric stretching modes of pure lanolin, 
Nuclepore-lanolin, Strat-M-lanolin and pig skin. 
 
Lanolin Nuclepore-lanolin Strat-M-lanolin Pig skin 
λCH2 St. Sym (cm
-1) 2848.5±0.01 2848.5±0.10 2848.5±0.03 2849.4±0.03 
λCH2 St.Asym (cm
-1) 2917.9±0.07 2917.9±0.19 2916.3±0.03 2916.9±0.08 
 
All the analyzed samples have a vibrational frequency of approximately 2849 or less 
corresponding in all cases to orthorhombic conformations. Low standard deviations 
were obtained in all the samples. These values agree with the ones corresponding to 
the natural lipidic packaging of pig healthy skin. Therefore, the two proposed synthetic 
models present a highly ordered lipidic structure that could emulate the lipidic 
package of the SC. 
The transepidermal water loss (TEWL) is commonly used to measure membrane/skin 
barrier function permeability and integrity. The loss of water across the membrane is a 
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valuable clue to determine whether a membrane is suitable to test the skin absorption 
(section 4.3). In this work, the TEWL values and their respective standard deviation 


















































Figure 29 Transepidermal water loss (TEWL) measured on skin, Strat-M, Strat-M-lanolin, 
Nuclepore and Nuclepore-lanolin. (*) indicates a P value ≤ 0.001 from the Kruskal Wallis 
test 
A low standard deviation was obtained in all the different membranes, including the 
skin. This is an important detail considering that it may imply homogeneity and 
stability not only on the skin biopsy but also on the commercial membranes (Strat-M 
and Nuclepore) and the presented lanolin-containing membranes from this work 
(Strat-M-lanolin and Nuclepore-lanolin). 
The skin biopsies are considered appropriate to be tested on Franz cell diffusion 
studies when values are equal to or below 15 g/m
2
/h [130]. Observing the values 
obtained from the commercial models, the TEWL values for Strat-M are lower than 
those for Nuclepore, indicating a better barrier function for Strat-M. However, their 
permeability is far away from the maximum accepted for the OECD guidelines. The 
TEWL results of Strat-M-lanolin and Nuclepore-lanolin indicate that the addition of 
lanolin brings an important reduction of the TEWL values, making the values 
comparable to those from the skin. Then, by adding lanolin to the original synthetic 
membrane, a significant reduction is observed, implying an increase in barrier 
function.  
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5.2.2. In vitro diffusion with Franz cell assembly of membranes 
In order to study the potential of the membranes to mimic the skin absorption, 
permeabilities of StratM, Nuclepore, Strat-M-lanolin and Nuclepore-lanolin and 
porcine skin are determined for three actives: Lidocaine, diclofenac sodium and 
betamethasone 17,21-dipropionate using the in vitro Franz cell diffusion methodology 
(section 4.3). 
These three actives were employed considering that they are commonly used in 
topical formulations as they were stated in section 5.1. Moreover, they have a 
different chemical nature (basic, acid and neutral respectively) and a different 
lipophilicity. The distribution coefficient (log 𝐷) at pH 7.4 and 5.5, as well as their 
molecular weight, were calculated in silico using the Pipeline Pilot software (Table XVI).  
Table XVI Molecular weight (MW) and octanol water distribution coefficients (𝐥𝐨𝐠 𝑫) at pH 
5.5 and 7.4 obtained from the Pipeline Pilot software  
Active (acidic nature) log 𝐷 at pH 5.5 log 𝐷 at pH 7.4 MW (g/mol) 
Lidocaine (basic) 0.61 2.33 234.34 
Diclofenac sodium (acid) 2.75 1.10 318.14 
Betamethasone 17,21-dipropionate (neutral) 3.96 3.96 504.59 
 
Log 𝐷 was determined at pH 5.5 because it is the pH of the skin surface, and log 𝐷 was 
determined at pH 7.4 because it is the pH of the receptor fluid and blood. As shown in 
Table XVI, betamethasone dipropionate, as a neutral active, showed no changes in 
log 𝐷 at the different pH values. By contrast, lidocaine (base) and diclofenac sodium 
(acid) showed opposite behaviors. At lower pH, the increase in the ionized form of the 
lidocaine caused a decrease in  log 𝐷, resulting in higher hydrophilicity. In the opposite 
case, the log 𝐷at pH 5.5 for diclofenac sodium was higher than that at pH 7.4 because 
the non-ionized form is predominant at acidic pH. This implies that, at pH 5.5, the 
log 𝐷 range is, from highest to lowest is betamethasone dipropionate> diclofenac 
sodium> lidocaine, with lidocaine the most hydrophilic compound. However, at pH 7.4, 
the log 𝐷 range is betamethasone dipropionate> lidocaine> diclofenac sodium, with 
diclofenac sodium the most hydrophilic compound. This could be important to predict 
or explain permeation of these actives through the different membranes. 
The three actives were formulated in propylene glycol at 2%, 0.5% and 1%. The passive 
diffusion of these three formulations was studied in Franz-cells systems  onto pig skin 
biopsies, lanolin-free synthetic membranes (Strat-M and Nuclepore) and lanolin 
synthetic membranes (Strat-M-lanolin and Nuclepore-lanolin). Table XVII contains 
normalised amounts after the HPLC analysis (4.6.1). 
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When pig skin biopsies were used, the amount of actives was evaluated in the Stratum 
Corneum (SC), epidermis (E), dermis (D) and receptor fluid (RF). Skin permeation (ABS) 
is considered the summed amounts from the epidermis, dermis and receptor fluid 
(Table XVII). 
When the actives were applied on the skin, lidocaine shows the highest permeation 
rates followed by diclofenac sodium. Betamethasone dipropionate was the less 
absorbed compound. As explained previously, log 𝐷 is an important parameter when 
studying diffusion across membranes. In the case of skin, log 𝐷 at pH 5.5 must be 
considered because this is the physiological pH in this tissue. When observing the 
log 𝐷 at pH 5.5 and molecular weight for the three actives, the absorption through the 
skin seems to be promoted by low molecular weights and low log 𝐷 values. Lidocaine 
(highly absorbed) is small and the most hydrophilic compound, followed by diclofenac 
sodium with a medium value of log 𝐷 and molecular weight. Betamethasone 
dipropionate is a lipophilic and heavy molecule poorly absorbed across the skin (Table 
XVII and Figure 30).  
 
Table XVII Normalized amounts (%) found in the Stratum Corneum (SC), epidermis (E) 
dermis (D) and receptor fluid (RF). In the case of artificial membranes, ABS belong to the 
amounts found in the receptor fluid. 









SC 5.02±4.56 9.70±4.25 13.60±3.37 
E 4.61±3.63 7.34±2.22 4.30±1.58 
D 2.94±0.96 1.84±1.53 0.00±0.01 
RF 50.02±10.05 11.68±6.17 0.00±0.00 
ABS  57.58±7.63 20.86±9.24 4.30±1.57 
Strat-M ABS 26.48±8.14 49.19±4.23 0.78±1.36 
Strat-M-lanolin ABS 68.40±6.50 45.22±9.36 4.03±0.59 
Nuclepore ABS 98.37±2.10 94.56±0.45 8.69±2.16 
Nuclepore-lanolin ABS 90.81±2.84 29.58±9.78 10.54±0.99 
*ABS: the absorbed amount through the skin is considered to be the sum of epidermis, dermis and receptor 
fluid 
The permeation obtained using the commercial membranes confirms the deductions 
made when observing the TEWL values. We observed higher values of TEWL on 
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Nuclepore than in Strat-M that could imply higher permeation on Nuclepore. Hence, 
the three different actives were more permeated in Nuclepore rather than in Strat-M. 
These differences were hardly seen on betamethasone dipropionate because the lack 
of solubility in the acceptor fluid limits its diffusion through the membrane (Figure 30).  
When observing the actives absorption rank in Strat-M, unlike on skin, diclofenac 
sodium was more permeated than lidocaine. Similar results can be deduced for 
Nuclepore, but its low barrier (demonstrated observing the TEWL values) does not 
allow the differentiation between lidocaine and diclofenac sodium. These permeability 
changes between diclofenac sodium and lidocaine can be explained observing their 
respective log 𝐷. As discussed previously, the pH at the skin is 5.5, whereas the pH at 
the commercial membranes is that of the receptor fluid, pH 7.4. Observing their 
respective log 𝐷, diclofenac sodium was demonstrated to be more hydrophilic than 
lidocaine at pH 7.4. Therefore, the same deduction observed when the actives were 
applied on the skin can be extracted: the most hydrophilic compound, which, in this 
case is diclofenac sodium, is more permeated than lidocaine. Betamethasone 
dipropionate with the highest log 𝐷 remains the less permeated compound. 
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Figure 30 Normalized absorbed amounts (%) in skin, Strat-M, Strat-M-lanolin, Nuclepore, 
Nuclepore-lanolin for lidocaine(a), diclofenac sodium (b) and betamethasone 
dipropionate (c) 
 
In summary, the lanolin layer was added to Strat-M and Nuclepore synthetic 
membranes. Comparing their TEWL values against those from the lanolin-containing 
membranes, an increment of the barrier function as a result for the lanolin addition 
was observed. The permeation results obtained for the three actives showed this 
barrier enhancement. The addition of lanolin promotes the reduction in the absorption 
of the three substances.  
Lanolin addition to the artificial membranes caused a reduction of TEWL and a 
modulation of permeation of the three different compounds, leading to results much 
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similar those obtained with the skin. Lanolin previously demonstrated its ability to 
reinforce SC lipids, leading to improved skin barrier function in in vivo topical 
studies[129]. This work confirms its suitability regarding its use as an artificial 
membrane for permeation or percutaneous absorption models. 
Part of the studies to prove similarity between the lipid matrix and lanolin wich are 
published in ”Skin Pharmacology and Physiology” entitled as “Solvent-Extracted Wool 
Wax Thermotropic Properties and Skin Efficacy” (Annex 2) 
The results from section 5.2 have been published as a research paper called “Lanolin-
Based Synthetic Membranes as Percutaneous Absorption Models for Transdermal Drug 
Delivery” in Pharmaceutics-MDPI (Annex 3). 
Besides these membranes and results  have been protected with a Patent (Annex 4) 
 
5.3. Comparison of in vivo stripping, in vitro permeation study and 
confocal Raman spectroscopy of resveratrol 
The objective of the present work is to examine and compare the skin penetration of 
an antioxidant such as resveratrol (Res) using in vivo and in vitro methodologies and 
applying also a spectroscopic technique such as confocal Raman microscopy with the 
same purpose.  
In a previous work, the in vitro percutaneous penetration using Franz diffusion cells 
was evaluated to assess compound delivery into the different layers of the skin (SC, 
epidermis and dermis) as well as into the receptor fluid when the compound applied 
topically on porcine skin[131]. Then, two other methodologies are presented in this 
doctoral thesis to study permeability of Res; An in vivo assay minimally invasive in 
which the SC in sequentially substracted with adhesive strips (section 1.2.3) and a 
confocal Raman microscopy (CRM) (section 4.7.1). These techniques were used to 
determine the penetration profile of resveratrol to be compared with the results of an 
ex vivo dermatomed porcine skin mounted in a Franz diffusion cell for 20h (section  
4.3).  
5.3.1. Percutaneous penetration of resveratrol by in vivo stripping 
In this work, the percutaneous penetration of resveratrol was determined in vivo on 
human skin. For these experiments, an aqueous-ethanolic solution (70:30) was 
selected as the simple application vehicle to dissolve the resveratrol to be used at the 
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5% (w/v) concentration. The in vivo penetration of resveratrol into the human skin was 
obtained using the stripping methodology (section 1.2.3), based on the successive 
extraction of the SC layers by consecutive stripping with adhesive tapes[132] described 
in section 4.5. 
The content of Res removed with the tape strips was quantified by triplicate with HPLC 
measurements (section 4.6.1) after methanol extraction of the combined groups of 
strips from 1–5 and 6–10 strips. The concentration of resveratrol obtained in the 
combined tapes, as a function of the strip number, is shown in Figure 31(expressed in 
percentage) and Table XVII (expressed in µg/cm
2
), along with the mean values. 
 
Figure 31 Concentration profiles of resveratrol (Res) from strips 1 to 5 and 6 to 10 in the 
SC in vivo, expressed as a percentage of the applied dose detected 




Volunteer 1 2 3 4 5 6 Mean ± SD 
Strips 1–5 3.99 12.17 1.89 8.61 8.24 19.72 9.10 ± 6.35 
Strips 6–10 1.06 3.11 0.83 3.45 3.63 0.83 2.15 ± 1.38 
Total amount (µg/cm2) 5.05 15.28 2.72 12.06 11.86 20.55 11.25 ± 6.56 
  
Taking into account the differences observed among the volunteers from Figure 31, 
the mean resveratrol recovery was 4.27 ± 3.35% (11.25±6.56 µg/cm
2
), and the majority 
was present on strips 1–5.  
The amount of SC extracted by the adhesive tape strips was dependent on a variety of 
factors [92], such as the anatomical site, subject age, and time of year. The quantity of 
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cells in the layers[133] and the thickness of the SC[134] change with the anatomical 
zone, corresponding to the changes in the composition and amount of lipids. External 
factors can also influence the quantity of the SC extracted by the stripping method. 
The mode of extraction from the skin, the pressure time on the forearm skin and the 
presence of topically applied substances are external factors[135] to take into account. 
In this work, efforts were made to control the intrinsic variability by carrying out the 
assays during the same time of year (over 2 days) for the group of volunteers and by 
using only the same area of the arm (the volar forearm). To take the external factors 
into consideration, the adhesive strips were attached to the skin surface with constant 
pressure and all the assays were carried out by the same technician. Despite 
considering the above factors, the amount of Res obtained showed a high variability. 
Moreover, the major amount (77%) of the penetrated resveratrol was localized to the 
upper layer of the SC (strips 1–5), and the compound detection decreased with the SC-
depth because smaller amounts of resveratrol were extracted and less SC tissue were 
removed by the tape strips from the deeper layers. 
5.3.2. In vivo stripping and in vitro Franz diffusion cells correlation results 
In vivo studies are essential assays for a more realistic evaluation of the skin 
permeation of topical applications. However, the usage of skin biopsies  with in vitro 
Franz diffusion cells is an alternative to in vivo methods. This in vitro method has been 
fully described in the previous sections (1.2.2.1). In a previous study[131], a specific in 
vitro percutaneous absorption was carried out to obtain the percutaneous profile of 
Res in the porcine skin. Figure 32 shows the comparison of the mean values from the 
in vivo study with the percutaneous absorption in vitro, expressed as a percentage of 
the applied amount recovered (%). 
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Figure 32 Percutaneous absorption of resveratrol in vitro expressed as a percentage of the 
amount detected in the different skin layers [Stratum Corneum (SC), epidermis (E), dermis 
(D)] and the receptor fluid (RF). The results were compared to the mean value obtained 
from the SC layer by the stripping method 
The results indicated that Res was located mainly in the SC layer and the viable 
epidermal layer. Resveratrol is immediately metabolized in the body[136]; thus, a 
topical administration could be an efficient option for its application to benefit the skin 
while avoiding the systemic presence of the compound. Other authors had established 
the permeation data of Res using different topical formulations[137]. The results 
obtained also indicated higher amounts of the compound in the skin than are observed 
from delivery at the systemic level. Therefore, the low capacity of percutaneous 
penetration observed for Res (0.6% skin absorbed[131]) may confirm its use as an 
ingredient in cosmetic products. 
The results obtained in vivo demonstrate that Res penetrates the SC layers, 
corroborating the results obtained in vitro. The percentage of Res obtained in the SC 
layer from the in vivo permeation (4.27 ± 3.35% of the applied dose) was similar to 
(not significantly different) that in vitro (3.36 ± 2.51% of the applied dose). 
5.3.3. Percutaneous penetration of resveratrol by CRM 
The CRM (section 4.7.1) technique was applied to obtain the spectra of Res and the 
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Figure 33 Raman spectra (100–3200 cm
−1
) of untreated pig skin acquired at the skin 
surface (a) and Res (b) 
The spectrum of the porcine membrane shows different bands that are distinctive for 
the lipids and proteins of SC layer, for example, the ring-breathing mode in Phe is 
shown at 1004 cm
−1
, amide I at 1650 cm
−1
, lipids at 2820 cm
−1
 and protein (keratin) at 
2940 cm
−1
. In Figure 35, the band at 995 cm−1, and the overlapped 1610/1640 cm−1 
pair detected in the spectrum of Res, can be used to follow Res permeation into the 
skin. The other peaks from Res, such as the ones in the 1003 cm
−1
 region, are as a 
result of the aromatic ring-breathing mode, and the ones in the 1610 cm
−1
 region are 
due to conjugated C=C bonds and ring-stretching modes. 
Res was topically applied to dermatomed pig skin mounted in a Franz-type cell (section 
4.3). After 24 h of exposure five tape strips were used to remove the excess compound 
from the skin surface. Afterwards, successive confocal Raman spectra from the applied 
skin were obtained every 7 µm to a final depth of 49 µm in the 600–2300 cm
−1
 region. 
The spectral series are shown in Figure 34. 
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Figure 34 Illustration of spectral changes obtained from the pig skin following the 
application of Res, at different depths. The top spectrum was collected at the surface of 
the skin, while the bottom one was collected 49 µm below the surface 
The spectral signals from both the skin and the applied Res compound are shown. The 
perception of the peaks in the 1610/1640 cm
−1
 region from the SC surface to a depth 
of ~49 µm demonstrated the penetration of Res to 49 µm into the skin. Modifications 
in the C=C peak regions and amplitudes are noted with the depth, as shown in Figure 
34. The results show the presence of Res in the SC compartment and in the viable 
epidermis. Relative Res concentrations were obtained from the Raman profiles, 
following the method described by Caspers et al. [138]. To rectify the variability of the 
absolute Raman intensity, which diminishes at the deeper levels of the skin, the 
corresponding coefficients were normalized to the Raman keratin signal (~2940 cm
−1
). 
Normalization to the Raman Phe ring peak from the SC layer (~1004 cm
−1
) was not 
considered because the intensity of this band increases due to the contribution of the 
vibration of Res at 995 cm
−1
 giving a signal that is superimposed with the skin Phe ring 
breathing[139]. The normalization approach revealed the amount of Res in the SC and 
viable epidermis relative to the amount of keratin. The depth concentration profiles of 
Res are presented in Figure 35. The highest concentration of the compound was 
obtained near the skin surface. The concentration decreased at a depth of 
approximately 20 µm. It can be observed that Res concentration was constant 
between the depths of 20–49 µm, corresponding to the viable epidermis. 
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Figure 35 Representative distribution profiles of Res in the porcine skin from 7 to 49 µm 
 
In this section 5.3, different in vitro and in vivo methodologies were used to assess the 
skin permeation of the antioxidant resveratrol after topical application. A depth 
concentration profile of resveratrol was obtained by CRM. The presence of bands in 
the 1610 cm−1 zone indicated that resveratrol permeated to a minimum of 50 µm. The 
results demonstrated that the percentage of resveratrol obtained from the in vivo 
permeation assay was similar to that obtained in vitro using the Franz cell system. 
The findings reported in the present study indicate the suitability of Raman microscopy 
and in vitro/in vivo percutaneous absorption procedures for the evaluation of 
resveratrol skin permeation. The active compound retained within the skin, especially 
in the SC, after topical administration may be an effective treatment for the mitigation 
of free radical exposure. 
This work is part of a research publication published in the Archives of Dermatological 
Research entitled “Skin permeation and antioxidant efficacy of topically applied 
resveratrol” (Annex 5) 
 
5.4. Confocal Raman spectroscopy of caffeine penetration on skin  
The combination of Raman spectroscopy with confocal microscopy (confocal Raman 
microscopy) is an optical technique to provide qualitative information about the 
biochemical composition of the skin, such as the lipid and water contents and the 
effects of moisturising factors [22, 23] . Moreover, the permeation profile of an active 
through the skin layers and its possible interactions with endogenous skin components 
can be studied with this technique (section 1.2.4). 
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Following, two CRM studies are described to obtain a quantitative evaluation of 
caffeine in SC and epidermis (section 5.4.1) and to evaluate the distribution of caffeine 
in the hair follicles using different mapping methodologies (section 5.4.2). Caffeine was 
chosen because it is one of the standard models commonly used as a hydrophilic 
tracer to evaluate skin absorption and penetration via traditional in vitro and in vivo 
methods[140,141] as well as in CRM studies[142]. 
 
5.4.1.  Percutaneous penetration of caffeine by CRM  
The present study seeks to optimize a methodology for completely quantitative 
measurement of the amount of caffeine (Caf) at different depths. A semi-quantitative 
depth profile was obtained with normalization of the Raman intensities. These ratios 
of Raman intensities were correlated with the caffeine concentration using an external 
calibration curve. The calibration curve was carried out with porcine skin incubated in 
different concentrations of caffeine; afterwards, each skin sample was analyzed by 
CRM and HPLC-DAD to determine the relation between the Raman signal intensity and 
the caffeine concentration per skin mass and to create a depth profile. These 
correlation curves allow full quantification of the caffeine in skin from Raman intensity 
ratios at different depths. Raman data acquisition and quantitative detection of 
caffeine are described in section 4.7.1. 
 
5.4.1.1. Quantitative CRM methodology optimization 
The porcine skin was incubated with different caffeine solutions and the skin samples 
were analyzed by CRM. Then skin samples were extracted and analyzed by HPLC to 
obtain correlation between the two techniques. 
Analysis of caffeine in epidermis by HPLC 
Caffeine (Caf) was extracted from epidermis (Ep) samples after 20 hours of incubation 
in solutions at different Caf concentrations. The extracted samples were analysed by 
HPLC-DAD (section 4.6.1) and the results are shown in Table XIX. As it can be seen, the 
percentage of absorbed caffeine per tissue mass is very similar in all the samples. The 
mean percentage of Caf recovery per mass of Ep (mg) was 0.100 ± 0.009%/mg Ep, 
demonstrating the low variability in caffeine absorption due to its similar penetration 
into tissues from different donors. 
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Table XIX Amounts of caffeine absorbed in the extraction of Ep after 20h incubation into 
caffeine solutions (expressed as µg Caf/mg Ep) and percentage of caffeine absorbed 
Solution of Caf concentration (µg/mL) µg Caf/ mg Ep  % Caf absorbed per mg Ep 
10.2 12.648 0.083 
5.0 7.711 0.104 
3.1 4.481 0.104 
1.7 2.497 0.105 
0.71 1.025 0.098 
Mean ± SD   0.100 ± 0.009 
 
Analysis of caffeine in epidermis by CRM 
To monitor a compound by CRM analysis, it is necessary to identify the Raman bands 
of the exogenous compound in the matrix correctly. Skin is a complex tissue containing 
multiple components that present Raman signals. Porcine skin was used in this CRM 
work as a substitute tissue for human skin because of similar permeability. Raman 
studies demonstrated the same band assignments in both types of skin, indicating the 
similar spectra of porcine and human skin[50,142]. The endogenous Raman peaks of 
skin can interfere with detection of the tested compound. The caffeine molecule 
presents defined Raman bands that permit its differentiation from skin components. 
Figure 36 presents the Raman spectra of caffeine (Caf), Ep incubated in caffeine 
solution (Ep+Caf) and untreated porcine Ep. 
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Figure 36 Raman spectra of caffeine (Caf), Ep incubated in caffeine solution (Ep+Caf) and 
untreated porcine Ep. 
The Ep spectrum shows various bands that are specific to skin, for example, the CC 
vibration mode of aromatic amino acids (AA) at 1004 cm
-1
 and the NC=O deformation 
in amide I (AI) at 1660 cm
-1
[142]. The caffeine band at 555 cm
-1
, assigned to the O=CN 
deformation mode, was selected as a marker because it has enough intensity and does 
not overlap with other bands from skin components. The spectrum of Ep with caffeine 
confirms the detection of the compound in the skin due to the clear identification of 
the Raman peak. The caffeine band at 1331 cm
-1
 was dismissed because of its overlap 
with the Raman bands of skin, as shown in the Ep+Caf sample (Figure 36).  
The variability in Raman spectra was estimated in the different Ep donors (data not 
shown). Despite the inter-individual variability in the intensity of the Caf peak in the 
spectra, the results did not indicate any significant differences between donors, as in 
previously investigations[143]. The absolute intensity of Raman bands decreases at the 
deeper levels of skin because of the lower resolution inside the sample. To rectify this 
Raman variability, the selected band of a compound can be normalised to a skin peak 
as an internal reference. Skin presents different peaks that can be used as a 
reference[138,142]. In this study, the caffeine peak of Ep samples (555 cm
-1
) was 
correlated to the aromatic amino acids and the amide I peaks (1004 cm
-1
 and  1650  
cm
-1
, respectively). Normalisation of the Caf peak to the Raman band of skin at 1290-
1311 cm
-1
 was not considered because the intensity of this skin band is compromised 
by the contribution of the caffeine vibration at 1305 cm
-1
. The variability of the 
normalised data from Raman signals was analysed along the depth. Figure 42 shows 
the ratio of the peak of caffeine (555 cm
-1
) with the two skin reference peaks (AA and 
AI) acquired at different depths. 
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Figure 37 Ratio peaks of caffeine (CAF) with the two internal references: aromatic amino 
acids (AA) at 1004 cm
-1
 and amide I (AI) at 1660 cm
-1
 at different skin depths 
The Ep surface position in spectral data was selected considering the aromatic amino 
acid peak at 1004 cm
-1
, which had the maximum intensity[144]. The Raman peak ratios 
of Caf vs aromatic amino acids and amide I remained constant at various Ep depths for 
each concentration of caffeine. This horizontal correlation demonstrated that the peak 
ratio is independent of the Ep depth, counteracting the attenuation in the Raman 
intensity. Low variability was associated with the normalised data of CAF/AA and 
CAF/AI ratios at each depth for all concentrations, as shown in Figure 37.  
 
Correlation of caffeine from HPLC/CRM analysis 
The ratio intensities (CAF/AA and CAF/AI) could be related to the concentration of Caf 
quantified by HPLC. The relation between both experimental data values permits a 
correlation between the CRM data and the quantitative amount of the compound. To 
establish a correlation between the normalised ratios and the caffeine concentration, 
Raman ratios were plotted versus the amount of caffeine (µg Caf/mg Ep) determined 
by HPLC analysis. The correlation is shown in Figure 38 for both cases. 
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Figure 38 Correlation between the Raman peak ratios obtained by CRM versus caffeine 
amount per mass of E determined by HPLC in different E depths 
Despite the dispersion in the plotted results due to the intrinsic variability of the skin 
samples, a mean linear correlation was obtained for both ratios. Linear regression 
equations for the experimental data were obtained with a good correlation, 
demonstrating that the relation for both signals was independent of Ep depth. 
Linear regression between the normalised ratios of caffeine and the amount of 
compound (µg Caf) contained in the Ep samples at different caffeine concentration 
enables quantification of the compound with skin profile data. Our study analysed 
caffeine in the SC and viable epidermis at depths up to 35 µm. These results 
corroborate the findings of Franzen et al.[143], even though those authors detected 
the compound only in an isolated SC. The obtained linear regression results were used 
to evaluate the penetration profile of Caf in an in vitro percutaneous study. 
 
5.4.1.2. Percutaneous penetration of caffeine determined by CRM 
For in vitro percutaneous penetration experiments, 20 µL of aqueous-ethanolic 
solution containing 5 % caffeine was applied to dermatomed porcine skin deposited in 
a Franz static diffusion cell. After 20 hours, the excess compound on the skin surface 
was removed with gently pressing of a tape strip. Afterwards, successive confocal 
Raman spectra were obtained every 5 µm to a final depth of 35 µm. The spectral series 
is shown in Figure 39. As in the Ep sample, the skin surface was considered the point at 
which the signal intensity of aromatic amino acids at 1004 cm
-1
 was maximal. 
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Figure 39 Illustration of spectra obtained of pigskin following the application of caffeine 
solution, at different depths (0 to 35µm). The top spectrum was collected at the surface of 
the skin, while the bottom one was collected 35 µm below the surface of the skin 
The presence of the peak at 555 cm
-1
 corresponding to caffeine demonstrated the 
penetration of this compound. The results show the presence of caffeine in the SC and 
in the viable epidermis. Relative caffeine concentrations were determined from Raman 
data using the aromatic amino acid and amide I bands of skin. The relative 
concentrations as a function of the skin depth represent the qualitative penetration 
profile of caffeine in skin. The semi-quantitative penetration profile of caffeine is 
plotted in Figure 40. 
 
 
Figure 40 Semi-quantitative penetration profiles of caffeine into the pig skin determined 
by CRM. Profiles were obtained for each internal skin reference 
As can be seen, the highest concentration of compound was detected close to the skin 
surface. The concentration appeared to level off at a depth of approximately 10 µm. 
The results showed that the caffeine concentration was constant between 10 and 35 
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µm, which are the depths corresponding to the viable epidermis. The two semi-
quantitative profiles obtained from the two internal skin references are qualitatively 
similar, but have different peak ratio levels due to the variability in the Raman band 
intensities of caffeine and skin components.  
The use of CRM for quantitative measurements requires a correlation between the 
Raman signal and the concentration of caffeine to convert the semi-quantitative data 
to quantitative data. In the previous experiment, we established a linear correlation 
between caffeine detected by CRM and the caffeine concentration quantified by HPLC. 
The semi-quantitative data of caffeine can be transformed to a quantitative 
penetration profile by applying the linear correlations for the Raman ratios and Caf 
concentration shown in Figure 38. The use of the CAF/AA and CAF/AI ratios in each 
linear regression equation provides the absolute value of caffeine at the different 
depths. Figure 41 presents the profiles for the absolute amount of caffeine in pig skin 
considering both internal skin references in the Raman data. As can be seen, the 
quantitative profile obtained from the CAF/AA ratio is close to the profile from the 
CAF/AI ratio, equalising the effect of the Raman signal. 
 
Figure 41 Quantitative penetration profiles of caffeine obtained from semi-quantitative 
data and linear correlation Raman-Caf concentration 
Until now, most studies carried out using the CRM technique presented semi-
quantitative results. Active compounds of dermo-pharmaceutical formulations applied 
in vivo can be analysed by CRM, a non-invasive method. Quantitative determination of 
compounds could be envisaged after in vivo evaluation following the CRM protocol 
presented in this work. More investigations are necessary with a wide range of 
compounds and experimental conditions in order to establish the correct and specific 
protocol for each case.  
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Summarizing, an experiment has been carried out to validate the use of confocal 
Raman microscopy to obtain a quantitative profile of the skin penetration of caffeine. 
A linear correlation between Raman signal ratios (ICAF/ISKIN) and the Caf concentration 
(µg Caf/mg Ep) obtained by HPLC was determined. Next, a semi-quantitative and even 
a quantitative depth profile of the Caf penetration in porcine skin was obtained by this 
technique. The transformation to quantitative data permits equalisation of the 
fluctuation of Raman data, providing a representative absorption profile.  
The presented procedure relates the Raman data and the caffeine concentration per 
skin mass. The findings provide further support for the application of CRM to the study 
of the drug disposition in skin via this non-invasive technique for direct quantification 
of a drug in skin. 
The results from section 5.4.1 are now under revision in the Archives of Dermatological 
Research entitled as “Caffeine delivery in porcine skin: a confocal Raman study”  
 
5.4.2. Imaging of follicular penetration of caffeine 
The trans follicular route for drug administration into the skin has gained attention 
mainly driven by the advent of nanoparticle-based delivery systems that facilitates the 
absorption into the hair follicle. Nevertheless, the study of the follicular penetration is 
challenging as it requires high spatial resolution and molecular sensitivity to the 
applied drugs. A suitable technique to fulfill this need is confocal Raman microscopy 
(CRM), which can combine the spectral and the spatial information in order to be used 
for hyperspectral imaging. Besides the spectroscopic analysis of the individual chemical 
composition, CRM offers the possibility of imaging by scanning the sample, thus, 
facilitating the visualization of spatially resolved component distribution.  
Comparison of the usefulness of Gaussian-peak fitting, classical least-squares (CLS) and 
Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS) models to provide 
semi-quantitative and spatially resolved information about the distribution of caffeine 
into the hair follicle is presented. Moreover, the differentiation of different 
constituents existing in the cryosections is achieved. 
Caffeine is applied to the non-dermatomed ear skin in two different formulations: 5% 
w/v in water: ethanol solution (50:50) (Caf-Aq) and 1.4mg/mL of caffeine nanoparticles 
coated with PVP in water (Caf-NP). Cross-sections containing a hair follicle of Caf-NP 
and Caf-Aq treated skin as well as a non-treated were studied. The followed procedure 
is detailed in section 4.7.2. 
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5.4.2.1. Reference component spectra 
Several components are observed in the mapped cryosections. First, their spectra were 
acquired. Figure 42 and Figure 43 show the pre-processed spectra of the reference 
components such as intrinsic and extrinsic skin components.  
Noticeable differences between the different tissue spectra (SC, hair, epidermis and 
dermis) can be observed. A major difference recognized in the hair spectrum is the 
Sulphur content, which is indicated by the relatively higher intensities of the S–S-
related band around 510–530 cm
-1
. This higher amount of sulfur is due to the higher 
amounts of sulfur-containing amino acids (cysteine) from the hair’s hard keratins. In 
the hair, 7–8% of the amino acids are cysteine, whereas in the SC (another highly 
keratinized tissue) it represents only the 0.5%[145]. The higher content of keratin in 
the hair is also disclosed by the higher amide I band at 1650 cm
-1
 compared to the 
other spectra. 
The SC shows some particularities compared to the hair, not only on the lower 
intensities of the bands related to the sulfur content previously detected (505 and 
1650 cm
-1
), but also for the presence of a prominent bank at 1064 cm
-1
 related to the 
skeletal C–C stretch of lipids[146]  
The dermis spectrum can be differentiated from that of the epidermis by the two 
double bands in the 815-850 and 920-940 cm
-1
 range. This pattern is representative for 
collagen[147], which is localized in the dermis in significantly higher quantities than in 
other tissue regions[148]. On the other hand, the amide I band associated to keratin 
(1650 cm
-1
) is higher for the epidermis than for the dermis, probably because of the 
higher keratinization of the tissue. 
The selected caffeine labelling band as in the previous section (5.4.1) is 555 cm
-1
 which 
is assigned to the δ C=O–N deformation modes[149](Figure 43). Regrettably, this band 
is slightly overlaid with one prominent band at 550 cm
-1
 attributed to Si-O-Si bending 
vibrations from the microscope slide glass. This band overlapping may cause difficulties 
to assign the spectral differences in this region to the presence of caffeine or glass if no 
further spectral analysis is performed. 
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Figure 42 Collected reference spectra of hair (blue), SC (green), epidermis (red) and 
dermis (purple) 
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5.4.2.2. Mapping methodologies for caffeine distribution 
After the discussion of the spectral differences from the different cross-section 
components, Peak fitting, CLS and MCR-ALS spectral analysis are studied to follow  the 
caffeine distribution within the mapped area. 
Peak fitting methodology 
The peak fitting methodology was used in the 555 cm
-1
 position to study the caffeine 
distribution in both hair follicles. Combining the amplitude values with the spatial 
information, images of the amplitudes within the sample are obtained. No trace of 
caffeine were apparently detected in in Caf-Aq (Figure 44) or treated with Caf-NP 
(Figure 45) hair follicles.  Large and uniform regions with high values of amplitude are 
detected in both hair follicles. When comparing with the microscopic images,  these 
bands are easily be attributed to the glass. The peak fitting in this region seems to be 
useless to detect caffeine’s distribution. Caffeine’s band at 555 cm
-1
 is partially 
overlapped with glass wider band at 550 cm
-1
, therefore the peak amplitudes of glass 
interfere caffeine’s detection with this method. 
 
Figure 44. Peak amplitude labelling at 555 cm
-1
for the Caf-Aq treated hair follicle 
 
Figure 45. Peak amplitude labelling at 555cm
-1
 for the Caf-NP treated hair follicle 
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Classical least-squares regression methodology (CLS) 
After processing the spectral data with CLS to identify the component distribution, a 
false color Raman image is obtained, allocating each pixel with a color representing the 
contribution of the reference Raman spectra. For both of the analyzed hair follicles all 
spots with spectra representing the dermis are shown in red, epidermis in yellow, hair 
in brown, SC in green, cover-slide glass in navy blue, caffeine in pink and cryospray 
drops in light blue. 
The loaded reference spectra were pre-processed as described in section 4.7.2. This 
approach displays differences in intensity scores and allows the spatial association of 
multiple components simultaneously in one pixel. Therefore this procedure facilitates 
a more detailed depiction of the distribution of the different components.  
 
Figure 46 CLS scores for the Caf-Aq treated hair follicle. Scores are plotted in: (red), 
epidermis (yellow), hair (brown), SC (green), cover-slide glass (navy blue), caffeine (pink) 
and cryospray drops (light blue) 
 
Figure 47. CLS scores for the Caf-NP treated hair follicle. Scores are plotted in: (red), 
epidermis (yellow), hair (brown), SC (green), cover-slide glass (navy blue), caffeine (pink) 
and cryospray drops (light blue) 
 
Comparing Figure 46 and Figure 47 with Figure 48 and Figure 49, respectively, the hair 
is correctly assigned in both cryosections. The epidermis and the dermis can be clearly 
differentiated in two different layers. The distributions of the three compounds (hair, 
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epidermis and dermis) fit the distribution in the microscopic image when compared 
side by side. 
The CLS analysis has more difficulties to correctly map the distribution of the SC. In 
Figure 46, the obtained scores are distributed not only on the skin surface, but also 
scattered on the hair and on the deepest region of the hair follicle (left side in Figure 
46). The SC is correctly marked in the infundibulum and external SC. After the 
infundibulum, the scores of the SC are rather discontinuous and less intense in both 
cryosections. One possible explanation could be that whereas in the upper 
infundibulum the epitelious is covered by intact SC, the barrier of the lower 
infundibulum is interrupted as the differential patter switches from epidermal to 
tricholemmal differentiation[22]. Therefore, the collected spectra in these regions are 
gradually changing to more “epidermis-like” features. The SC scores are also plotted 
broadly nearby the cryospray drops, in the deeper area of the mapped area. It should 
be remarked, that in this area also other components are not well allocated. The 
scores of hair, SC and glass are mapped in this region but none of these components 
are observed nearby in the microscopic image. Therefore, it seems that the cryospray 
drops may interfere the measurements, clogging up the correct component 
identification in this area. The caffeine is observed mainly surrounding the upper part 
of the hair in the image but also accumulated in the SC of the outer part of the follicle. 
It should be noted that the hair follicle was applied with a caffeine solution in water. 
Hereby, the absence of permeation enhancer in the formulation would suggest that 
caffeine will have strong difficulties to go through the skin or the hair follicle. 
Therefore no significant amounts of caffeine are expected in the deeper layers of the 
skin. 
On the other hand, in the Caf-NP treated hair follicle Figure 47 the epidermis and 
dermis are well assigned. The SC is also distributed near the infundibulum and the skin 
surface. Nevertheless, some areas are difficult to interpret, especially on the upper-left 
side of the image. No considerable amounts of caffeine are detected surrounding the 
hair, the main caffeine contributions are located in the formulation drop on the right 
side of the image. 
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Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS) 
The same areas analyzed by CLS are also analyzed with MCR-ALS. The resulting caffeine 
scores are plotted in red superimposed to their respective acquired microscopic 
images (Figure 48 and Figure 49). The spectrums of glass, dermis, epidermis, SC, hair, 
caffeine and cryospray drops were employed as starting estimates for the calculations.  
When the caffeine scores of the Figure 48 are examined, similar conclusions 
concerning the caffeine distribution are observed comparing to the CLS scores. The 
caffeine scores for the MCR-ALS analysis show that the caffeine is mostly allocated 
surrounding the outer part of the hair. Also the caffeine is distributed near the upper 
infundibulum and the outermost SC from the skin surface. Moreover the diffusion of 
caffeine from the SC to the deeper layers of the dermis can be observed. In regards to 
the caffeine scores nearby the cryospray drops this area showed previous 
misidentification therefore they can be considered as artifacts. 
 
Figure 48. MCR-ALS scores for caffeine (red) in the Caf-Aq treated hair follicle, overlaid on 
2 subsequently recorded stitched microscopic images with 10× magnification. 
 
Figure 49. MCR-ALS scores for caffeine (red) in the Caf-NP treated hair follicle 
Relating to Figure 49, the higher values of MCR-ALS caffeine scores are distributed in 
the formulation drop and in one thinly area from the stratum corneum. These caffeine 
scores  distribution is also coincident with the scores obtained in the CLS analysis.  
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To sum up, different spectroscopic analysis to study caffeine’s distribution into the hair 
follicle when vehiculized in two different formulations were applied. Cross sections of 
the tissue were mapped and analyzed with CRM. CLS and MCR-ALS analysis give to a 
similar distribution of caffeine into the hair follicle with much better resolution than 
peak fitting. Both methodologies seemed to be useful when the active and the skin 
bands are overlapped. Nevertheless, the spectroscopic analysis should be further 
studied to ensure that the resulting distribution is linked only to the active and not to 
areas with noise or higher fluorescence. 
The work from section 5.4.2 was carried out during a 8 month stay in the “Center of 
Experimental and Applied Cutaneous Physiology” leaded by Prof. Jürgen Lademann in 
the Universitätsmedizin of Berlin 
One publication related with confocal Raman microscopy entitled “Surface 
determination of 3D confocal Raman microscopy imaging of the skin” was published in 
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6. CONCLUSIONS 
― The selected in silico methods (Potts and Guy, Mitragotri and Barratt) predicted 
the permeability constant (log 𝐾𝑝) of the substances, taking into account their 
respective physico-chemical properties. In general, lower Kp values were 
obtained using the Barrat model for the compounds with higher melting points. 
However, all the models agreed that tazarotene had the highest permeability and 
that eflornithine had the poorest permeability mainly based on their lipophilic 
properties 
― The in vitro assay Skin-PAMPA with artificial membranes was performed with 23 
actives using aqueous buffer at pH 5.5 or propylene glycol. When the buffer was 
employed, the actives showed a high range of permeability constant (from -10 to 
-5), which diminishes (from -9 to -7) when the substances are vehiculated in 
propylene glycol. This solvent, which is well known as a skin enhancer, modulates 
permeability by increasing the permeability of compounds with poor 
permeability and diminishing the permeability of actives with high permeability.  
― Percutaneous absorption with pig skin on Franz diffusion cells was performed on 
10 actives and the commercial creams of five of them. The active amounts in the 
different skin strata (Stratum Corneum, epidermis and dermis) and the receptor 
fluid were determined. Distribution of compounds was in general found to 
decrease when going in depth through the skin.  
― The five creams evaluated tend to decrease the permeability, with lower 
amounts of active in all the skin layers (SC, E and D), but maintaining the 
compound distribution in the different strata. Results indicate that, in general, 
creams have lower permeation rates than PG solutions alone. 
― The role of the formulation in skin penetration and retention of compounds was 
studied in depth with three corticoids formulated in propylene glycol, and 
commercial creams and ointments. The influence of PG on the maximum 
amounts of analyte in the SC and E and similar amounts in the D for PG and 
ointments with a much lower level of creams was found. This suggests the 
relevance of the solvent drag effect in skin delivery for the tested actives. 
― Correlations between permeation models indicate very poor results. Linear 
correlations between the two Pampa lists of values and the three in silico models 
were very low. However, the results of the skin-PAMPA assay at pH 5.5 and the 
amount of the compound in the epidermis and dermis of the Franz cell data of 




effectiveness of the two in vitro assays at assessing the formulation and the 
detrimental effect of propylene glycol. 
― Structural lipid modification due to propylene glycol used on formulations was 
performed by ATR-IR. Epidermis and dermis were found to be modified not only 
altering the lipidic order of the bilayer structure but also changing the C-O band 
attributed to phospholipids, glycerides and esthers. This could be one of the 
reasons of the poor correlation between permeation methodologies when 
actives are formulated with PG. 
― Lanolin was added to synthetic membranes to mimic the lipids from the skin for 
permeation studies. Their highly lipidic order as an orthorhombic structure 
significantly reduces the TEWL values, similar to the porcine skin levels. Besides a 
modulation of the permeation of three different compounds, were similar to 
those obtained with the skin. In conclusion, combining synthetic membranes 
with lanolin may be a useful approach to mimic the absorption of topical actives. 
― Percutaneous penetration of resveratrol was also determined by in vivo 
stripping, based on the successive extraction of the SC layers by consecutive 
stripping with adhesive tapes. A good correlation was obtained with the use of 
pig skin with Franz diffusion cells. 
― Confocal Raman Spectroscopy was optimized to determine the skin penetration 
of Caffeine. A quantitative analyses was achieved until 35µm depth at the 
epidermis. Moreover the mapping methodologies for caffeine distribution shows 
the allocation of the active surrounding  the outer part of the hair with much 
better map distribution using MCR-ALS and CLS calculations. Nevertheless further 
studies should be carried out to optimize caffeine detection  and avoid 
interferences. 
Summarizing, the in silico models gives only a rough idea about actives 
penetration. The Skin-PAMPA needs an improvement of the lipidic membrane, 
therefore an approach was suggested with the use of lanolines. The influence of 
vehicles on skin penetration was determined with Franz diffusion cells with pig 
skin and the lipid skin modification of propylene glycol was demonstrated with 
µFTIR. Results of all these methodologies were combined with a poor correlation 
between them. However, the in vivo stripping approach was successfully 
correlated with the Franz diffusion cells one. Quantitative permeation 
determination and mapping resolution obtained by CRM provides further 
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